The drug situation in Norway 2003 by Hordvin, Odd
Norwegian Institute for 
Alcohol and Drug 
Research (SIRUS)
Øvre Slottsgate 2B,
0157 OSLO, Norway
Phone.: +47 22 34 04 00
Fax: +47 22 34 04 01
www.sirus.no
ISBN 82-7171-251-9
D
es
ig
n 
&
 p
ro
du
ks
jo
n:
 w
w
w
.k
ur
si
v.
no
Annual report to the European
Monitoring Centre for Drugs and
Drug Addiction – EMCDDA
2003
The Drug Situation in Norway
Norwegian Institute 
for Alcohol and 
Drug Research
Th
e D
ru
g
 Situ
atio
n
 in
 N
o
rw
ay 2003
1N A T I O N A L  R E P O R T  2 0 0 3  –  S I R U S
Content
Introduction ................................................................................................................................. 3
Summary...................................................................................................................................... 5
Part I  NATIONAL STRATEGIES: INSTITUTIONAL & LEGAL FRAMEWORKS ...................................... 7
Chapter 1. Developments in Drug Policy and Responses ...................................................... 7
1.1 Political framework in the drug field ............................................................................... 7
1.2 Legal framework ............................................................................................................. 9
1.3 Laws implementation – Case law priorities and goals relating to drug users 
and drug-related crime.................................................................................................. 10
1.4 Developments in public attitudes and debates .............................................................. 11
1.5 Budget and funding arrangements................................................................................ 11
PART II  EPIDEMIOLOGICAL SITUATION ...................................................................................... 12
Chapter 2. Prevalence, Patterns and Developments in Drug Use ....................................... 12
2.1 Main developments and emerging trends ..................................................................... 12
2.2 Drug use in the population ........................................................................................... 13
2.3 Problem drug use.......................................................................................................... 19
Chapter 3. Health consequences............................................................................................ 21
3.1 Drug treatment demand ............................................................................................... 21
3.2 Drug-related mortality ................................................................................................... 22
3.3 Drug-related infectious diseases .................................................................................... 25
3.4 Other drug-related morbidity ........................................................................................ 26
Chapter 4. Social and Legal Correlates and Consequences ................................................. 29
4.1 Social problems ............................................................................................................. 29
4.2 Drug offences and drug-related crime........................................................................... 29
4.3 Social and economic costs of drug consumption ........................................................... 30
Chapter 5. Drug Markets ........................................................................................................ 31
5.1 Availability and supply................................................................................................... 31
5.2 Seizures......................................................................................................................... 31
5.3 Prices ............................................................................................................................ 35
Chapter 6. Trends per drug..................................................................................................... 37
Chapter 7. Discussion.............................................................................................................. 38
7.1 Consistency between indicators .................................................................................... 38
7.2 Methodological limitations and data quality .................................................................. 38
N A T I O N A L  R E P O R T  2 0 0 3  –  S I R U S
2
PART III – DEMAND REDUCTION INTERVENTIONS....................................................................... 39
Chapter 8. Strategies in Demand Reduction at National Level........................................... 39
8.1 Major strategies and activities ....................................................................................... 39
8.2 Approaches and new developments.............................................................................. 40
Chapter 9.  Prevention ............................................................................................................ 42
9.1 School programmes ...................................................................................................... 43
9.2 Youth programmes outside schools ............................................................................... 45
9.3 Family and childhood .................................................................................................... 47
9.4 Other programmes........................................................................................................ 48
Chapter 10. Reduction of drug-related harm........................................................................ 50
10.1 New initiatives in 2003.................................................................................................. 50
10.2  Description of interventions........................................................................................... 51
10.3  Standards and evaluation .............................................................................................. 52
Chapter 11. Treatment ............................................................................................................ 53
11.1 Drug-free treatment and healthcare .............................................................................. 53
11.2 Research on treatment and evaluation .......................................................................... 54
11.3 Substitution and maintenance programmes .................................................................. 55
11.4 After-care and re-integration ......................................................................................... 58 
Chapter 12. Interventions in the criminal justice system .................................................... 59
12.1 Assistance to drug users in prison ................................................................................. 59
12.2 Alternatives to prison .................................................................................................... 60
12.3 Further training ............................................................................................................. 60
Chapter 13.  Quality Assurance.............................................................................................. 62
PART IV  SELECTED ISSUES ......................................................................................................... 63
Chapter 14  Evaluation of Drugs National Strategies .......................................................... 63
14.1 Existence of evaluation.................................................................................................. 63
14.2 Methodology of evaluation ........................................................................................... 63
Chapter 15. Cannabis problems in context: 
understanding increased treatment demand ........................................................................65
15.1 Cannabis use in the general population ........................................................................ 65
15.2 Demand for treatment for cannabis use ........................................................................ 65
15.3 Prevalence of problematic cannabis use and patterns of problems ................................ 68
15.4 Specific interventions for problematic cannabis use ....................................................... 69
15.5 Conclusions................................................................................................................... 71
Chapter 16. Comorbidity ........................................................................................................ 72
16.1 Main diagnoses, prevalence .......................................................................................... 72 
16.2 The impact of comorbidity on services and staff............................................................ 74
16.3. Service provision for persons with drug abuse and psychiatric complaints ..................... 74
16.4 Examples of best practice and recommendations for future policy................................. 79
References ................................................................................................................................. 84
Annexes ..................................................................................................................................... 85
Abbreviations ............................................................................................................................. 86
3N A T I O N A L  R E P O R T  2 0 0 3  –  S I R U S
Introduction 
The report on the drug situation in Norway 2003 is compiled by SIRUS as the National focal point,
for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).  The report is based
on collected data and written contributions from central public institutions and important players in
the alcohol and drugs field in Norway.  Part I was mainly written by the Ministry of Social Affairs.
The external authors who contributed to parts II and III are mentioned under “co-authors”. The
authors of part IV are listed under each specific chapter. 
Most of the data in the report are from 2002. For seizures of narcotic substances and tendencies
and trends, a summary has been included for the first six months of 2003. 
Senior advisor Odd Hordvin has edited the report. An internal reference group in SIRUS, consisting
of director Knut Brofoss, head of research Sturla Nordlund, advisor Hege C. Lauritzen, researcher
Astrid Skretting , researcher Einar Ødegård and advisor Marte K. Ødegård Lund, has commented on
and approved the written contributions and the data. 
I would like to thank everyone, both at SIRUS as well as external partners, for their contributions.  
Oslo, November 2003
Knut Brofoss
Director
Head of Focal Point  
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External co-authors:
Bønes,Tormod, National Criminal Investigation Service: Chapter 5.
Blystad, Hans, The Norwegian Institute of Public Health:  Chapter 3.3
Heir, Ole Johan/Fjeld Rune, Ministry of Justice, Department of Prison and Probation: Chapter 2.2.3
Drug use in prison; Chapter 12.
Iversen, Erik, the Bergen Clinics Foundation: Chapter 3.1.
Svenkerud, Siri, The Borgestad Clinic: Chapters 8 and 9.
Waal, Helge, Unit for Addiction Medicine, University of Oslo, Chapter 11.3
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Summary – Main trends and developments
• The most marked change in relation to 2001 is the strong reduction in the number of drug fatal-
ities in 2002. Figures from the National Criminal Investigation Service show that 210 persons died
as a consequence of narcotic substance abuse in 2002. This is almost 40% fewer than in 2001,
when 338 such deaths were reported. The reduction may have several causes, including reduced
heroin availability, less pure heroin, the fact that an increasing number of opiate users are in sub-
stitution treatment and the considerable increase in low threshold health services. 
• There was no demonstrable increase in the use of narcotic substances among young people
between the ages of 15 and 20 from 2002 to 2003. SIRUS’ survey of 15-20 year-olds for 2003
shows a marked increase in the use of alcohol, but no major changes from 2002 as regards the
use of and attitudes to illicit drugs. 
• Various data sources and surveys show that drugs are being increasingly used and sold outside
Oslo. There are hardly grounds for claiming that the number of young people at risk has increased,
but the rural – urban constellation is in a process of change. Moreover, the socio-cultural dimen-
sion with increased availability of new substances in new milieus is a relatively clear trend viewed
in a longer-term perspective.
• An increasing number of drivers are caught driving under the influence of narcotic and medicinal
drugs. The increase from 2001 to 2002 is much greater than any previously recorded – almost
20%. The samples taken reveal the presence of illicit drugs and a high proportion of medicinal
drugs, particularly tranquillizers and sleeping pills. Figures showed a doubling in the incidence of
Rohypnol. 
• At the same time we have seen a clear increase in the number of seizures of several of the most
common illegal substances in 2001 and 2002. Figures for 2002 show that the biggest absolute
increases were for benzodiazepines and amphetamines. Seized quantities of benzodiazepines also
increased markedly, particularly the quantities of Rohypnol.
• Figures for the first six months of 2003 show, however, a clear decrease in the number of drug
cases and seizures. This applies to most substances, except LSD and GHB, and is particularly
marked for ecstasy, benzodiazepines, cocaine and heroin. On the other hand, there have been
many big seizures of most types of drugs.  
• In 2003 efforts to expand low threshold health services for heavy problem users have been inten-
sified. There has again been a steep rise in the number of clients in medically assisted rehabilita-
tion. 
• From 2002 ownership and operational responsibility for hospitals passed to the state. It is expect-
ed that also the counties’ responsibility for institutions and associated specialist services for the
treatment of drug users will be transferred to the state from 2004. A bill (Drugs and Alcohol
Reform 2) is scheduled for consideration by the Storting in the autumn of 2003. The aim is to
implement the reforms concurrently, with effect from 1 January 2004. 
• The Government’s new Action plan to combat alcohol and drug problems (2003-2005) outlines
strategically important goals for a policy on drugs and alcohol. As part of the implementation two
expert advisory committees were appointed in 2003 – one on alcohol and one on drugs. The com-
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mittees are to provide the Government with ongoing advice about specific drug policy challenges,
evaluate interventions, propose new ones and stimulate the development of more knowledge.
• On commission from the Minister of Social Affairs, a research commission has summarised exist-
ing knowledge on the effects of drug abuse prevention measures, identified a need for further
research and pointed out political dilemmas and possibilities in this area in coming years. The com-
mission submitted its report in February 2003. On the basis of this report, among other things, the
Ministry of Social Affairs is now considering the future organisation of drug and alcohol-related
research and the prioritisation of research topics.
7N A T I O N A L  R E P O R T  2 0 0 3  –  S I R U S
Part I: National strategies: Institutional &
legal frameworks
Chapter 1. Developments in Drug Policy and Responses
1.1 Political framework in the drug field
Objectives and priorities of national drug policy
Norwegian drug policy is based on a comprehensive, multidisciplinary approach, in which preven-
tion and treatment measures are balanced by concurrent measures aimed at control and supply
reduction. Norway has pursued a restrictive drug policy ever since the use of drugs became a social
problem among young people in the mid-1960s, banning both possession, non-medical use and
sale of the substances in question. 
Important strategic objectives for the Government are to: 
• Reduce the supply of illegal narcotic substances
• Reduce all illegal use of drugs
• Increase the number of successful treatment forms for drug problems
• Reduce morbidity and other social and health-related problems associated with drug abuse.
Drug policy requires new modes of thinking in order to meet the dramatic increase in the availabil-
ity and use of drugs that has taken place over the last decade. Increased experimentation, new nar-
cotic substances and more users with extensive health and social problems require new solutions
and an extension of those measures that have proven effective. Long-term, goal-oriented work is
needed in order to reduce drug-related problems.
New action plan
On 3 October 2002 the Government proposed a new action plan to combat alcohol and drug 
problems, for the period 2003-2005. The challenges and strategic choices reflected in Norwegian
drug policy are based on the following objectives:
• Pursue a policy that both reduces alcohol and drug problems and is supported by the general 
population
• Strengthen the municipalities’ and local communities’ preventive efforts, with particular emphasis
on preventive and health-promoting initiatives aimed at children and adolescents in schools and
in educational and leisure activities.
• Ensure that problem users and their close families receive quality treatment and rehabilitation/
follow-up so that the individuals concerned can live a dignified life.
Through the action plan, the Government wishes to provide the basis for a broad-based strategy 
of effective measures that cover the entire alcohol and drugs field. The plan stresses the following
specific target areas:
• Integrated, locally-based measures to combat alcohol and drug use among children and young
people, and alcohol and drug problems in general
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• Treatment and care for the most problematic users
• Increased international cooperation
• Improved coordination of efforts
• Knowledge production and quality assurance.
The use of illegal substances is in principle unacceptable both out of consideration for individuals
and the society at large, and prevention work is based on this principle. 
A separate system for follow-up is being developed, consisting of annual performance targets, spe-
cific measures to be implemented within certain deadlines, and a system for evaluating target attain-
ment. The action plan takes into account that developments may require changes and adjustments,
for example as a result of the emergence of new narcotic substances. 
Treatment and rehabilitation of drug users
The government is strengthening the treatment offered through redistribution of responsibility for
measures to help drug users. Particular emphasis is placed on strengthening the competence and
efforts of the health-care services vis-à-vis this group. It also aims to ensure more comprehensive,
individually adapted treatment alternatives, so that the clients avoid being passed from one agency
to another in the area.
Medically assisted rehabilitation for heavily dependent heroin users has been available nationally
since 1998. National guidelines have been draw up concerning responsibility for and the organisa-
tion of medically assisted rehabilitation at regional and local levels. The system is based on spe-
cialised regional centres, but the municipal health and social services are responsible for follow-up.
Experiences in this area are being evaluated.
Reduction of drug related harm
A number of damage-reducing measures have been established for the most dependent problem
users whereby continued use of drugs is accepted to a greater or lesser degree. Existing low-thresh-
old health services for drug users have been strengthened through a significant increase in govern-
ment grants. Low-threshold health services are important instruments in combating overdose fatal-
ities. The services offered include health checks, vaccinations, the distribution of user equipment,
protection against infectious diseases, guidance and follow-up after overdoses. 
A majority in the Storting has requested the government to facilitate trials with drug injection
rooms. The government is drafting the required legislative amendments which will be put forward
as soon as possible.
Nordic and international cooperation
Increased international cooperation is regarded as one of the most important factors if we are to
succeed in reducing the availability of drugs in the years to come.  International cooperation - both
at regional and global level - is considered one of the main elements of Norwegian drug policy, and
is an important element in a comprehensive approach to fighting drug abuse. Since 1970 Norway
has been an active participant in joint Nordic efforts aimed at combating drug problems, since 1979
through the Nordic Council of Ministers.  The joint Nordic effort includes cooperation between the
police and customs authorities, research, continual exchange of information about the drug situa-
tion and related measures, coordination as far as possible of the countries’ views in international
forums, and measures aimed at developing cooperation with neighbouring regions. At the
European level, Norway is a member of the EMCDDA and the Council of Europe’s Pompidou Group.
Norway has ratified the UN conventions on drugs, is a member of the UN Drugs Commission 2004-
2007 and one of the main contributors to the UN’s work against drugs. 
9N A T I O N A L  R E P O R T  2 0 0 3  –  S I R U S
Organisation and coordination at central and local levels
The main responsibility for coordinating drug policy, including preventive measures, care and treat-
ment, lies with the Ministry of Social Affairs (formerly the Ministry of Health and Social Affairs). The
Ministry of Health has now been given a clearer responsibility for developing health services for drug
users.
Three central bodies work on drug prevention:
• Norway Net, consisting of seven regional competence centres on drug and alcohol issues
• The Directorate for Health and Social Affairs
• The Norwegian Institute for Alcohol and Drug Research (SIRUS).
They operate in the areas of education and competence development, quality and intervention
development, grant administration and research and documentation.
Pursuant to the adopted guidelines, the municipalities are responsible for preventive measures, as
well as procuring places on treatment programmes for drug users. The basic principle is that the
services must be anchored in the local community. Drug and alcohol policy is regarded as an impor-
tant part of Norwegian welfare policy, and cooperation with other local services and sectors is vital.
It is not only necessary to coordinate social services for drug users, but also their dealings with the
mental health services, child welfare services and primary health care services. Moreover, close coop-
eration is also necessary with respect to housing assistance, the labour market and educational sys-
tem. Voluntary organisations make an important contribution, including ownership and operation
of treatment centres and residential facilities, often with public funding. 
The police work to prevent drug-related crime in two ways: firstly, by reducing the availability of
drugs through police investigations and interventions and, secondly, by spreading information about
the harmful effects of drug abuse. The police run an active information service aimed at different
youth groups, parent groups and schools, in which the strategy is to prevent recruitment of new
groups to the drug scene. 
Research commission
On commission from the Minister of Social Affairs, a research commission has summarised existing
knowledge on the effects of drug abuse prevention measures, identified a need for further research
and pointed out political dilemmas and possibilities in this area in coming years. The commission
submitted its report in February 2003. On the basis of this report, among other things, the Ministry
of Social Affairs is now considering the future organisation of drug and alcohol-related research and
the prioritisation of research topics.
1.2 Legal framework
Norway has no specific legislation that exclusively addresses drugs. Legislative responsibility is divid-
ed between the Ministry of Justice (the Penal Code), the Ministry of Social Affairs (the Social Services
Act) and the Ministry of Health (the Act on Medicinal Products, the Act on municipal health servic-
es and the Act on specialist health services). The provisions of the Norwegian Penal Code were
explained in the National Report for 2002.
Legislative and regulatory changes
Section 21 of Act no. 21 of 18 May 2001 on the execution of sentences opens for treatment as an
alternative to imprisonment. In contrast to earlier practice, admission to treatment can take place at
the time deemed most expedient for the convicted person’s rehabilitation, and not necessarily
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towards the end of the term in prison, which was the main rule under the now revoked Act no. 7
of 12 December 1958 on the execution of sentences, section 12. Decisions relating to the serving
of sentences in an institution (cf. the Execution of Sentences Act section 12) are generally made by
the Correctional Service at local level (cf. the Sentences Execution Act section 6). For persons sen-
tenced to long prison terms (more than 10 years) or special sanctions, and high-security prisoners,
the decision shall be taken at the regional level. The Correctional Service must not decide on alter-
native forms of serving sentences if security grounds dictate against doing so, or if there is reason
to assume that the convicted person will evade completing the programme.
The Act on execution of sentences also authorises the use of various forms of compulsory measures,
among other things with a view to preventing the use of drugs during the serving of a sentence.
Section 29, for example, authorises the use of urine samples, breathalyser tests or blood tests to
detect such use.
From 2002 ownership and operational responsibility for hospitals passed to the state. It is  expect-
ed, that also the counties’ responsibility for institutions and associated specialist services for the
treatment of drug users will be transferred to the state from 2004.
In the autumn of 2002, the Ministry of Social Affairs introduced a bill proposing legislative amend-
ments (“Drugs and Alcohol Reform 1” - Odelsting proposition no. 3 2002-2003). The proposed
amendments were adopted by the Storting in January 2003. The Ministry of Social Affairs has fur-
thermore introduced a bill (Odelsting proposition no. 54 2002-2003) containing proposals for the
future organisation of interventions for which the counties will remain responsible under the Social
Services Act (Drugs and Alcohol Reform 2). The bill is scheduled for consideration by the Storting in
the autumn of 2003. The aim is to implement the reforms concurrently, with effect from 1 January
2004. 
Responsibility for the further development of low threshold health services and medically assisted
rehabilitation was transferred to the new Ministry of Health with effect from 1 January 2002.
In March 2002 the Penal Code Commission submitted its final report on amendments to the
Norwegian Penal Code, in which a majority of the Commission’s members proposed decriminalising
the purchase, use and possession of small quantities of drugs for personal use, and reducing the
maximum prison terms for drug offenders from 21 to 10 years. However, the Minister of Justice has
rejected allowing any discussion of decriminalisation in the follow-up of the report, with reference
to the Government's objective of opposing all forms of legalisation of narcotic substances. 
1.3 Laws implementation – Case law priorities and goals relating to drug
users and drug-related crime
Practice shows that the penalty for drug-related crimes is largely dependent on the substance and
quantity involved. Involvement with cannabis is subject to more lenient sentencing than involvement
with more dangerous substances. The nature of the involvement is also a very important issue with
respect to sentencing. Greater leniency is shown in cases involving the importation or purchasing of
drugs intended for personal consumption than in cases where the act was motivated by profit.
In three recent court decisions (Norwegian Legal Gazette 1999, p. 33 and p. 1504 and the Supreme
Court’s decision of 6 September 2000), the Supreme Court very clearly emphasises the need to
clearly distinguish between the purchase and possession of drugs intended for personal use and the
purchase and possession of drugs intended for sale. In the Supreme Court’s decision of September
2000, the first voting justice stated that this decision, in his opinion, "must be understood to entail
a change of practice" compared to previous practice. It appears, therefore, that the Supreme Court
wishes to make even more of a distinction than previously between involvement with drugs intend-
ed for personal use and involvement with drugs intended for resale.
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1.4 Developments in public attitudes and debates
One issue of current interest is the ongoing debate relating to the open drug user scene around
Oslo’s central railway station and the recruitment of new young people to heavy drug abuse.  It has
been claimed that one should draw on experience of models that have been tested with positive
results in other European cities – such as Frankfurt.
Critics point to what they argue is an imbalance between the severity of the crime and the guide-
lines pursuant to which different drug-related crimes are punished. The general level of punishment
for crime in Norway is regarded as relatively low, while the level of punishment for drug-related
crimes is tough. Individual citizens and lawyers have also raised doubts about how effective the cur-
rent penal system is in preventing drug abuse, and asked whether the restrictive Norwegian control
system perhaps creates more problems than it solves. 
1.5 Budget and funding arrangements
In addition to the normal funding of operations, the Ministry of Social Affairs and the Ministry of
Health have extraordinary budgetary funds at their disposal for the development of special high pri-
ority programmes in the areas of epidemiology, research, prevention and treatment. Such funds are
channelled through SIRUS, the Directorate for Health and Social Affairs, the regional competence
centres on drug and alcohol issues, specialised centres for substitution treatment and low-threshold
measures. As funds are allocated to a large number of public bodies, institutions and organisations,
either as operational funding or as allocations to projects, it is very difficult to present exact figures
in relation to specific areas. 
In the research area (including alcohol, drugs and tobacco), SIRUS was allocated a total of EUR 3.43 1
million in operational funding in 2003.
In 2002 the Ministry of Social Affairs allocated approx. EUR 21.6 million towards the development
of social services and drug and alcohol measures2. Priority areas in 2002 included the following: 
• Drug and alcohol prevention work at the local level
• Competence building
• Strengthening of the municipal social services’ work to help drug users
• The work of voluntary organisations in the drugs area.
1 Exchange rate used: 1 Euro = 8 NOK
2 Government funds at the disposal of the Directorate of Health and Social Affairs are discussed in chapter 9 d).
Grants towards the reduction of drug-related harm are discussed in chapter 10.1
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PART II: Epidemiological situation
Chapter 2. Prevalence, Patterns and Developments in Drug Use
2.1 Main developments and emerging trends
There was no demonstrable increase in the use of narcotic substances among young people
between the ages of 15 and 20 from 2002 to 2003. SIRUS’ survey of 15-20 year-olds for 2003
shows a marked increase in the use of alcohol, but no major changes from 2002 as regards the use
of and attitudes to illicit drugs. On the contrary, the surveys from the last two years appear to indi-
cate that the trend may be towards reduced consumption and more restrictive attitudes to narcot-
ic substances among young people in this age group. 
No equivalent surveys have been made of the adult population in the last two years. 
But the fact that an increasing number of drivers are caught driving under the influence of narcot-
ic and medicinal drugs is an indication of prevalence in the adult population. In 2002 the number
of cases increased by 20%. The samples taken reveal the presence of illicit drugs and a high pro-
portion of medicinal drugs, particularly tranquillizers and sleeping pills. Figures from the Norwegian
Institute of Public Health (NIPH), for instance, show a doubling in the incidence of Rohypnol. 
Various data sources and surveys show that drugs are being increasingly used and sold outside Oslo.
There are hardly grounds for claiming that the number of young people at risk has increased, but
the rural – urban constellation is in a process of change. Moreover, the socio-cultural dimension with
increased availability of new substances in new milieus is a relatively clear trend viewed in a longer-
term perspective. 
The estimated number of active intravenous users, most of whom inject heroin, indicates that the
number is still increasing slightly from one year to the next. We still lack reliable estimates of other
forms of problem use, such as persisting use of amphetamines, ecstasy and cocaine. 
The most marked change in relation to 2001 is the strong reduction in the number of drug fatali-
ties in 2002. Figures from the National Criminal Investigation Service (NCIS) show that 210 persons
died as a consequence of narcotic substance abuse in 2002. This is almost 40% fewer than in 2001,
when 338 such deaths were reported. The reduction may have several causes, including reduced
heroin availability, less pure heroin, the fact that an increasing number of opiate users are in substi-
tution treatment and the considerable increase in low threshold health services. 
At the same time we have seen a clear increase in the number of seizures of several of the most
common illegal substances in 2001 and 2002. NCIS’ seizure figures for 2002 show that the biggest
absolute increases were for benzodiazepines and amphetamines. Seized quantities of benzodi-
azepines also increased markedly, particularly the quantities of Rohypnol. There was, on the other
hand, a marked decrease in the number of heroin and ecstasy seizures, but in the case of ecstasy
the quantities seized are large and have increased significantly. GHB, classified as a narcotic sub-
stance in 2000, still constitutes only a very small proportion of the total quantity seized. 
NCIS claims that there is much evidence to indicate a relationship between developments relating
to ecstasy and heroin and the police and customs authorities’ investigations, and that there is rea-
13
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son to believe that the big seizures have limited the supply of these substances in the market, which
in turn has led to fewer seizures among users. It is difficult to read changes in use directly from the
seizure figures, but it will be interesting nevertheless, to keep an eye on developments, especially in
the use of heroin and on whether the considerable number of persons now in medically assisted
rehabilitation, will result in a reduced demand for heroin.
2.2 Drug use in the population
2.2.1 General population
The most recent national interview survey on the Norwegian population’s use of alcohol and other
intoxicants was conducted in 1999. The main data from this survey were presented in the report for
2002. The next interview survey is scheduled to take place in 2004. The questions will be adapted
to the EMCDDA’s standards, so that the data can be compared with that of other EU countries (stan-
dard table 013). 
Registration of the drug situation in some selected municipalities
In 2002 SIRUS registered the drug situation in 60 selected municipalities by collecting information
relating to the situation in 2001 from respondents in three public services in each municipality.
Similar surveys have been conducted since 1992, but using different questionnaires so that the data
are not comparable. 
The 60 municipalities constitute a relatively representative selection of the country’s municipalities in
terms of both size and geographical distribution. All the counties were represented and the biggest
municipality in each county was included. The selection was broken down into large municipalities
(Oslo, Bergen, Trondheim, Stavanger and Bærum), 21 medium-sized municipalities (with popula-
tions of between 20,000 and 99,000) and 34 small municipalities (with populations of between
1,000 and 19,000).
The 60 selected municipalities included a total of 50% of Norway’s population at 1 January 2002
(Statistics Norway: Population statistics).
Data for the 2002 survey were collected from the police, health and social services and outreach
services. They were all asked to estimate the number of drug users in their municipality, whether
they had observed any increase in the availability of drugs and the priority given by the service in
question to drug-related work during the year. The response was high (83-91.5%) for the three 
services involved. 
Since the survey concerned selected municipalities only, the data do not provide an overall picture
of the situation for the country as a whole. Comparisons of the data are mostly on the basis of the
three municipal size categories. Moreover, the data are largely based on information about persons
known to the respondents. The data can therefore tell us something about tendencies and trends,
but not about prevalence. 
In most of the selected municipalities both the police and social services had the impression that
there had been a general increase in the number of users of narcotic substances from 2000 to 2001.
Very few respondents believed that there had been a decrease in number of users of any of these
substances. Most respondents mentioned cannabis, amphetamines and tranquilizers as substances
where the number of users had increased. 
3 All standard tables referred to in this report have been submitted to the EMCDDA separately 
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Tranquilizers stood out as a “substance category” believed by many of the informants to have
attracted more users. Rohypnol was mentioned most frequently. 
As regards amphetamines, more than half of the respondents reported that the number of users
had increased in the last year. None of them thought that the number of amphetamine users had
decreased or that this substance was not available in the municipality. 
In general, the police have the most "dramatic" assessment of changes in drug use.
In summary, the informants seem to think that young people under 18 mostly use cannabis and
amphetamines. Most typical users of all narcotic substances are found in the 18-41 age group, while
there are few in the over 41 age group who use amphetamines and ecstasy.
One third of the social service informants and almost half of the police informants reported that opi-
ates are also taken by smoking. 
More generally, the social services report that more drug abusers are injecting, regardless of the type
of drug, and that they are experimenting with various combinations of drugs (www.sirus.no).
In 2003 the collection of data will be extended to include all of Norway’s 434 municipalities, and the
data will therefore give a more complete picture. The purpose of this annual reporting is primarily
to provide information about how the situation is changing. Together with other methods, the reg-
istration will also enable us to provide more reliable estimates of problem drug use.
2.2.2 Young people
Annual youth survey 2003 
SIRUS conducts an annual questionnaire survey on the use of drugs among young people aged 15-
20. The 2003 survey showed no major changes in the use of illegal substances. In recent years the
difference between the proportion of young people at national level and the proportion of young
people in Oslo who state that they have used various drugs has continued to decrease. While at the
national level the proportion stating that they have used cannabis, ever and during the last six
months, has been 15-17% and 8-10%, respectively, for the last three years, the corresponding fig-
ures for young people in Oslo are approx. 25-28% and 7-12% (figures 1 and 2). 
Figure 1. Percentage of young people aged 15-20 in Norway who report having used cannabis, ever and
during the last six months, 1986-2003.
Source: SIRUS
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Figure 2. Percentage of young people aged 15-20 in Oslo who report that they have used cannabis, ever and
during the last six months, 1968-2003 (three year sliding average).
Source: SIRUS
With respect to the percentage who report having used other substances, the trend has largely flat-
tened out in the last few years (figures 3 and 4). For example, the proportion of 15-20 year olds who
report ever having tried ecstasy has remained at approximately 3% for the nation as a whole and
4-5% in Oslo. However, there appears to have been an increase in the percentage who report ever
having used cocaine.
Figure 3. Percentage of young people aged 15-20 in Norway who have ever tried different narcotic 
substances, 1986-2003.
Source: SIRUS
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Figure 4. Percentage of young people aged 15-20 in Oslo who have ever used different narcotic 
substances, 1970-2003 (three-year sliding average).
Source: SIRUS
As regards the availability of illicit drugs, the situation seems to have been relatively stable in recent
years, measured by the responses to the question of whether or not young people have been
offered various substances. At the national level, the proportion of 15-20 year olds stating that they
have been offered cannabis has been around 40% for the last five years, while the proportion stat-
ing that they think they would be able to get hold of cannabis in a matter of 2-3 days should they
want to do so, has been around 65%. Similarly at the national level the proportion stating that they
have been offered amphetamines and ecstasy has been approximately 14-17% and 13-14% respec-
tively. 
In Oslo the proportion of 15-20 year olds stating that they have been offered cannabis has been
approx. 55%, the proportion stating that they would be able to get hold of cannabis in the course
of 2-3 days has been approx. 70%, while the proportion stating that they have been offered
amphetamines or ecstasy has been around 20-25% and 17-22%, respectively.
The 2003 survey confirms the tendency in recent years that the proportion expressing that they have
a positive attitude to narcotic substances is no longer increasing. In the last two or three years
approx. 10% of 15-20 year olds at national level and 13% in Oslo have stated that they think
cannabis should be sold freely in Norway.
Statistical error margins
The figures are subject to statistical error margins and must be interpreted with considerable care.
Questionnaire surveys are always susceptible to certain sources of bias (not everyone responds, some
responses contain deliberate or inadvertent errors, etc.) and the surveys referred to here targeted
young people in general. There is reason to believe that young people who regularly use narcotic
substances, whether it be cannabis or stronger substances, will be underrepresented in the surveys
(www.sirus.no). 
The ESPAD survey 2003 (the Norwegian part)
The European School Survey Project on Alcohol and other Drugs (ESPAD) is a European question-
naire survey on the use of drugs among 15-16 year olds. The survey is conducted in 30 countries,
including Norway. Three sets of data are now available – from 1995, 1999 and 2003. The interna-
tional report in which Norway will be compared with other European countries will be available in
2004. 
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The Norwegian part of the survey includes just under 4,000 10th year students (9th year students
in the 1995 survey). 
The main results relating to the use of drugs in the three surveys are shown in tables and figures. A
more comprehensive report including updated results from the Norwegian 2003 survey will be avail-
able in the autumn of 2003.
Cannabis
While there was quite a dramatic increase from 1995 to 1999 in the proportion stating that they
had used cannabis, there was a clear decrease in 2003 in the proportion stating that they had used
cannabis ever (figure 5), during the last 12 months (figure 6) and in the last 30 days (figure 7),
respectively. As illustrated by the figures, the decrease from 1999 to 2003 is quite marked. The same
tendency can be observed in the annual youth surveys for the group aged 15-20. 
Figure 5. Percentage of boys and girls who state that they have ever used cannabis.
Source: SIRUS
Figure 6. Percentage of boys and girls who have used cannabis during the last 12 months. 
Source: SIRUS
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Figure 7. Percentage of boys and girls who state that they have used cannabis during the last 30 days.
Source: SIRUS
Other narcotic substances
There was also a decrease for other narcotic substances from 1999 to 2003. The figures are small
however and must be interpreted with care. One-two per cent state that they have ever used
amphetamines, ecstasy, cocaine and heroin. The proportion stating that they had ever used medic-
inal drugs like Valium, Rohypnol and Mogadone without a doctor’s prescription was 2.7% in 1995,
3.5% in 1999 and 2.5% in 2003.
Sniffing
There was a gradual decrease from 1995 to 1999 which continued until 2003, except in the pro-
portion stating that they had sniffed solvents during the last 30 days (www.sirus.no).
2.2.3 Drug use in prison
The prison population reflects in concentrated form the problems that exist outside the prison walls.
The percentage of inmates serving sentences for violation of drug laws has been increasing in line
with the increasing problems experienced in the rest of Norway. In 2001 just under 30% of inmates
in Norwegian prisons at any given time, had been convicted of various drug crimes. Additionally,
some prisoners have been convicted of drug-related crimes that are directly related to drug use, but
that are not reflected in the statistics. Typical examples of this are theft and robbery committed in
order to finance drug use.
The prison authorities estimate that around 40-60% of inmates in Norwegian prisons use drugs
once or more during their term in prison. This estimate is based on previous studies carried out in
prisons, including anonymised questionnaire surveys among inmates, and reports submitted to the
Prison Board by prisons and from inspection rounds.
After the Act of 18 May 2001 on sentence execution entered into force, the prisons have improved
access to control measures to combat drug use. Among other things, they have been authorised to
take urine and blood samples on a general basis. Another new feature is that sniffer dogs can be
used for searches of the person. Additionally, the right to search visitors has been introduced, and
the right to hold these individuals until the police arrive. Moreover, health care personnel, on the
request of the prison, can conduct body searches (cavity searches) of inmates in the case of sus-
pected use or possession of drugs. There are also a number of other control measures, including the
use of blue lighting in toilets, sniffer dogs and communication checks. 
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The number of body searches (cavity searches) has remained stable from 1993 to 2002. The total
number of finds of drugs and user equipment increased from 1988 to 2002. In 1988 there were
234 finds of drugs and 777 finds of user equipment, while in 2002 the number of finds was 651
for drugs and 1,008 for user equipment. The increase may be due to increased prevalence and use
of drugs in prisons, but may also be related to improvements in the control procedures.
The number of urine samples testing positive for drugs increased from 1,019 in 1988 to 1,999 in
2002. But, given that the total number of samples taken increased from 6,706 to 21,663 in the
same period, the percentage testing positive dropped substantially from 15.2% to 9.2%. Some of
the decrease can be explained by the fact that the statistics have become more precise since 2002,
when legal narcotic substances (medicinal drugs and legally prescribed methadone/ subutex) and
drugs taken before arrival in the prison were no longer included in the figures for illegal intake in
proven samples. This means, in other words, that approx. 90% of the urine samples show no traces
of illicit drug intake in prisons. The majority of the positive tests are for cannabis substances and var-
ious narcotic tablets. This corresponds with the seizures that are made (Ministry of Justice ) (Standard
table 12). 
Cannabis is the clearly most frequently found substance in samples from inmates in prisons and
open facilities (figure 8). Amphetamines and diazepam (active agent in e.g. Valium) are also fre-
quently detected. This picture has not changed much in recent years, but an increase in fluni-
trazepam, the active agent in e.g. Rohypnol, has been registered (NIPH).
Figure 8. Drugs detected in correctional service cases
Source:   NIPH
2.3 Problem drug use
Estimates relating to the extent of problem drug use in Norway are based on the number of over-
dose fatalities. The estimates indicate the scope of intravenous abuse. In 1989 the number of inject-
ing users at the national level was estimated at 4-5,000, in 1999 at 9-12,000, in 2001 at 10,500-
14,000 and in 2002 at 11–15,000. This corresponds to a doubling from 1990 to 1999 and proba-
bly a continued modest increase since then. 
Heroin is the predominant injected drug. Amphetamines and cocaine may also be injected, but
intravenous users of these drugs seldom die of an overdose. Hence, intravenous use of these sub-
stances will be underrepresented in the figures. Sustained or regular use of opiates, amphetamines
or cocaine, when these substances are not injected, will not be included in the estimates of intra-
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venous users. The actual extent of problem drug use is therefore greater than 11-15 000 persons.
Approx. one third of the intravenous users are women, and this figure has remained stable over
time. 
The problem user population seems to be getting older. Studies of persons visiting the needle bus
in Oslo show that their average age has increased somewhat. This may be because few people are
able to stop problem use and that the population of intravenous users is therefore growing older.
The increase in average age may also be due to recruitment taking place from older age groups than
previously. 
The growth indicated by the above estimated figures for intravenous drug use, does not necessari-
ly mean that recruitment is continuing to increase. Even lower recruitment will contribute to an
increase in numbers if few persons stop their problem use or die. The increase in the number being
treated with methadone from 1999 to 2002 and stability in the numbers of places in other forms
of treatment, indicate that the proportion who stop being active injecting drug users is higher than
it used to be. This may be an indication that recruitment to intravenous drug use is not on the
decrease. 
The municipal survey from 2002 and indicators of problem use around the country provide a basis
for alternative methods of estimating problem use at the national level. Work on such supplemen-
tary figures relating to problem use has not yet been completed (standard table 7).
Risk behaviour
Risk behaviour associated with injecting relates to the risk of infectious diseases, injuries sustained
from incorrect injection and the risk of overdosing. In addition, surveys show that this group has
poor general health and nutrition, particularly for heavy problem users. They are therefore very
receptive to infections and disease in general. 
Experience of caring for drug and alcohol abusers and various low threshold responses show a large
under-consumption of ordinary medical services among drug users. Low threshold responses include
health services that do not require prior appointments and that target the problems of drug and
alcohol abusers. Other services include accommodation and food, and other forms of care and activ-
ities. Needle distribution and free condoms are often an integrated part of these services. Such low
threshold responses have been introduced in the big cities and some populous municipalities near
cities (chapter 10).
HIV testing continues to be extensive among intravenous users, with almost 90% having tested
themselves in the last three years. The prevalence of HIV among intravenous users in Norway
remains stable and low compared with most other European countries, even if the number of new
cases registered in 2002 was the highest for many years (chapter 3.3). In a survey among users of
the needle bus in Oslo (Hepatitis C survey by the Alcohol and Drug Addiction Service in Oslo), more
than 70% stated that they were aware of their hepatitis C status, 58% stated that they had tested
positive and 14% that they had tested negative. Blood tests showed the presence of hepatitis C
antibodies in 80% of the same group.
The extent of needle sharing has been measured using roughly comparable questions in surveys
from 1992/2000 (User surveys of the needle bus) and 2002 (the Hepatitis C survey) among users of
the needle bus. In 1992, 32% of all respondents stated that in the course of the last four weeks
they had used a needle used by someone else (including their regular partner) before them. The
2000 and 2002 surveys showed somewhat lower figures – around 16%. This may indicate that
there was a reduction in needle sharing over the ten-year period (SIRUS) (standard table 10). 
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Chapter 3. Health consequences
3.1 Drug treatment demand
Norway has established a registration system for the treatment of clients with drug and alcohol
problems. The system is based on a client registration form, which is used to register the clients’ sit-
uations on requesting treatment, the client’s situation at the time treatment begins, and situation
on the completion of treatment. The form is to be completed by the therapist based on an inter-
view with the client, and should include variable sets that cover the ”core items” in the EMCDDA’s
Treatment Demand Indicator. The system is designed to suit the needs of clients with both alcohol,
prescription drug and illicit drug problems. 
Because of official regulations protecting the right to privacy, data from the client registration sys-
tem is collected at the facility/ institution level before it is collated at regional and national levels as
aggregate figures for each facility/institution. The fact that national data are only available in the
aggregate form means that it is not possible to distinguish clients whose problems are purely or pri-
marily alcohol-related from clients whose problems are primarily drug-related. The form in which
data are available also makes it impossible to check for duplicate data, i.e. treatment in which the
same client appears for several treatment sessions in the same or different facility/institutions in the
same year. The client cannot be ”followed through the system” over time.
Work is now in progress to develop an individualised registration system that can be used in con-
junction with the EMCDDA’s Treatment Demand Indicator. Proposals have been drafted for an
encryption system for data and personal identifiers for individual facilities / institutions, a system for
secure data transfer from institutions to a central data administration, for choosing a central data
administrator and storage system, and a provision concerning access to centrally stored data. These
elements are, however, subject to approval by the Data Inspectorate. The Ministry of Health and the
Ministry of Social Affairs are involved in this process.
Table 1. Registered requests for and initiated treatment. 
Note: The same person may be registered more than once in the same year. Includes both individuals whose
problems are primarily alcohol-related and those whose problems are primarily drug-related.
Source:  The Bergen Clinics Foundation
Table 1 shows the development of registered requests and initiated courses of treatment from 1998
to 2001. The records for 2002 are being collected. The fall in the number of institutions responding
in 2001 was caused by reorganisation in Oslo and computer problems in several facilities/ institu-
tions. Altogether, in the four years from 1998 to 2001, 145 different facilities/ institutions have sup-
plied data to the client registration programme. Eighty facilities/ institutions have provided data in
all four years. 
When broken down by gender and age, the requests show a clear tendency towards a more even
gender distribution the younger the clients. In 2001 women represented 43% and men 57% of the
Year No of resp. No. of requests No. of initiated 
institutions etc. courses of treatment 
1998 110 18,115 13,541  
1999 110 20,426 15,700  
2000 113 26,462 18,981  
2001 106 23, 280 17,850  
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requests in the 16-20 age group, while the figures were 21% for women and 79% for men in the
51-60 age group. Gender differences between different age groups followed the same trend in
1998, 1999 and 2000.
Alcohol is the most frequently used intoxicant among most men, used by approx. 36%, while 28%
of the men use heroin/ other opiates most frequently. The most frequently used intoxicants among
women are alcohol (28%) and heroin/other opiates (also 28%). Addictive prescription drugs are the
most used drug among many more women (9%) than men (slightly over 3%). Ecstasy was the most
frequently used drug in 14 cases in 1998, in 18 cases in 1999 and in 82 cases in 2000. The figures
for 2001 show that ecstasy is the most frequently used drug in 49 cases (figures 11 and 12 in chap-
ter 15)
Addictive medicinal drugs are the “second most used drug” by most clients, followed by cannabis.
Alcohol and heroin/ other opiates are stated as being the “second most used drug” by approx. 4-
5%, for both genders. In 153 cases ecstasy was the second most used drug, while in 27 cases it was
LSD (the Bergen Clinics Foundation).
3.2 Drug-related mortality
There are two bodies in Norway that register drug fatalities: Statistics Norway (SSB) and NCIS. SSB’s
figures are based on medical examiners’ reports, autopsy reports and doctors’ declarations of death.
SSB codes cause of death by using a Norwegian version of the international classification of dis-
eases, accidents and injuries (ICD-10). The deaths included in these statistics are registered accord-
ing to their determined underlying cause, i.e. drug use is the direct cause of death. NCIS’ registra-
tion system is based on reports received from police stations around the country.  
The figures from NCIS include cases of acute poisoning (overdoses) as well as deaths that are clear-
ly related to the deceased person’s abuse. Experience indicates that the actual number of drug-relat-
ed deaths will be somewhat lower once autopsy reports become available from the Institute of
Forensic Medicine. NCIS uses unadjusted figures for previous years, however, in order to have a cor-
rect basis for comparison. 
Table 2. Drug-related deaths. Total number of deaths and broken down by gender. Figures from NCIS and SSB
(underlying cause of death).
1991-2001 Number of deaths according to NCIS Number of deaths according to SSB    
Men Women Total Men Women Total
1991 74 22 96 66 22 88  
1992 78 19 97 81 23 104
1993 77 18 95 76 17 93  
1994 102 22 124 105 19 124  
1995 108 24 132 114 29 143  
1996 159 26 185 173 31 204  
1997 149 28 177 160 34 194  
1998 226 44 270 228 54 282  
1999 181 39 220 191 65 256  
2000 264 63 327 302 72 374  
2001 286 52 338 327 78 405  
2002 166 44 210 
*  The figures from 1996 and onwards have been classified after a new revision. Hence the figures before and
after 1996 are not directly comparable. Suicides in which narcotic substances were used are included as
from 1996.
Source:  NCIS and SSB 
23
N A T I O N A L  R E P O R T  2 0 0 3  –  S I R U S
NCIS’ records show that the number of drug-related deaths fell markedly in 2002.  The police dis-
tricts report a total of 210 deaths - 166 men and 44 women – as a result of drug use in 2002. This
is 128 (almost 40%) fewer than in 2001 when 338 deaths were reported, and the lowest figure
since 1997.  
The average age of the deceased in 2002 was 33 years for men and 34 years for women. All togeth-
er 23 of a total of 27 police districts reported drug-related deaths in 2002. As in previous years, the
Oslo Police District reported the highest number of deaths (79). More than one in three drug-relat-
ed deaths took place in the capital, although Oslo’s share of the total has been decreasing in recent
years (standard tables 05 and 06). 
Methadone-related deaths
A comparison of the presence of methadone in forensic autopsies (i.e. test material analysed by
NIPH) with the sale of methadone, shows a very strong correlation between the total quantity pre-
scribed and the number of poisoning fatalities in which methadone was an important factor. A
sharp rise has been seen in the number of such deaths over the last few years, paralleling the
increase in the quantities prescribed. Poisoning by methadone alone accounts for 10% of the mate-
rial on which figure 9 is based, while the rest being mainly combined poisonings.
Figure 9  Methadone-related deaths in Norway 1991-2002
Source:  NIPH
THC-related deaths
In a study in 2001 of autopsy cases in which tetrahydrocannabinol (THC - the active agent in
cannabis) was found to be present, six cases of sudden death without a clear cause of death were
reported. By comparing identified THC concentrations, clinical data and autopsy findings the study
found indications of acute heart failure in these persons. THC intake and its timing in relation to the
symptoms, or in some cases death, have not previously been documented by measuring THC levels
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in the blood. Cannabis is generally considered a fairly non-toxic substance, involving little danger of
serious poisoning or death. 
However, this study concluded that cannabis has a considerable acute effect on the cardiovascular
system both in healthy individuals and those with heart conditions, and suggests that there may be
a correlation between cannabis use and sudden heart failure. Such serious, but rare side effects can
be detected after a substance has apparently been used safely over a long period of time (Bachs, L.
and Mørland, H.). 
Causal factors
The major changes in the total number of drug fatalities have no simple explanation. Factors that
may have contributed to this development are:
• The number of intravenous drug users has doubled over the last 10 years
• A more prevalent injecting culture in Norway than in other countries, including the other Nordic
countries. In Norway heroin is taken almost exclusively by injecting.
• The heavy drug user group has grown older and is more debilitated both physically and mentally.
• Except in 2002, heroin has been readily available and therefore dropped in price, which in turn
has led some users to use larger doses.
• Multiple use, whereby heroin is taken in combination with alcohol and/or prescription drugs such
as Rohypnol, has become increasingly common.
The substantial decrease in the number of drug fatalities in 2002 may be partly due to the sharp
increase in the number of persons undergoing medically assisted treatment, both in Oslo and in the
rest of the country. There has also been an increase in the number of low threshold services in the
cities and big towns. 
Mortality among heavy drug users in Norway has been calculated in several follow-up studies.
However, it is problematic to generalise from group-specific mortality rates to the entire population.
Bretteville-Jensen and Ødegård (1999) emphasise the uncertainty attached to their estimate, which
is based on a review of the available literature and stipulates an annual mortality rate of between 3
and 4% among intravenous drug users.  
The establishment of a Norwegian register of drug fatalities
In order to follow the development in deaths due to overdoses and be able to evaluate the treat-
ment programmes and preventive measures, it is absolutely necessary to establish a register of drug
fatalities based on a uniform registration method. The Ministry of Health has therefore given the
Norwegian Institute of Public Health the task of establishing a national register based on uniform
registration. In order to stay in step with international developments, it is also important to ensure
that statistics are comparable with the statistics of other countries. A reference group has been
established, consisting of representatives from forensic medicine, NCIS, SIRUS, the Directorate of
Health and Social Affairs and SSB. 
The project is in its first phase, which will consist of drawing up definitions of drug fatalities and cri-
teria for subdivision into categories. Among other things, it is important to find criteria to distinguish
overdose deaths from other causes of death, such as traffic accidents and suicides.  In addition to
the conclusions from forensic autopsies and forensic toxicology findings, reports from the individual
police districts to NCIS will be important sources of information. 
The criteria for classifying drug fatalities adopted by the EMCDDA will be helpful in establishing the
Norwegian register. In addition to harmonisation with other European countries, it is important that
the new register covers specifically Norwegian conditions. 
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So far the project has been allocated funding for 2003 and the register is expected to be in place in
2004. So far, it has not been decided which body will be responsible for maintaining and operating
the register (NIPH). 
3.3 Drug-related infectious diseases
HIV and AIDS
In 2002, 205 cases of HIV infection were reported to the Reporting system for infectious diseases
(MSIS). Only 16 of these cases concerned intravenous drug users. This represents a slight increase in
newly diagnosed cases compared with recent years, but it is too early to say whether this represents
an increase in the spread of disease among drug users. Half of these cases were reported from Oslo,
eleven were men and five were women and the mean age was 36 years. Two of the cases concerned
immigrants infected before arriving in Norway, both from Eastern Europe. At 31 December 2002, a
total of 472 persons were registered as HIV positive with injecting use as the risk factor. This is 19%
of all reported cases of HIV since 1984. 131 of the cases have been reported as having progressed
to AIDS (table 3) (standard table 09). 
Table 3. Proportion of intravenous drug users among persons infected by HIV or AIDS, showing risk behaviour
in the form of injecting use, by year of diagnosis.
Intravenous users were the group for whom fears of an uncontrolled spread of infection were great-
est. The incidence of HIV in this group has, however, remained stable over the last decade with
about 10-15 cases of HIV infection a year. The reason for this is not fully clear, but a high level of
testing and degree of openness concerning HIV status in the user milieus, combined with a strong
fear of being infected and self-imposed discipline, are assumed to be important factors. Additionally,
many of the sources of infection in the drug-using milieus have disappeared through deaths from
overdosing or rehabilitation through substitution or other treatment. However, the extensive out-
breaks of hepatitis A and B in recent years, and the high incidence of hepatitis C, show that needle
sharing is still prevalent. The situation as regards HIV is therefore regarded as very unpredictable.
HIV HIV- intravenous Percentage of AIDS AIDS Percentage of
Total drug user HIV intravenous total Intravenous AIDS- intravenous 
drug user drug user drug user
1984-89 894 315 35% 144 8 6%  
1990 90 22 24% 59 13 22%  
1991 142 16 11% 59 16 27%  
1992 105 12 11% 50 8 16%  
1993 113 13 12% 64 13 20%  
1994 94 12 13% 74 19 26%  
1995 105 11 10% 67 8 12%  
1996 116 9 8% 56 12 21%  
1997 113 11 10% 34 8 24%  
1998 98 8 8% 39 5 15%  
1999 147 12 7% 29 7 24%  
2000 176 7 4% 38 6 16%  
2001 158 8 5% 27 5 18%  
2002 205 16 8% 33 3 9%  
total 2 555 472 18,5% 773 131 17%  
Source: NIPH
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When the virus was introduced to this group in the mid-eighties, around 250 drug users were prob-
ably infected in the course of a three-year period, which demonstrated how fast HIV can spread in
user environments. The group’s high HIV test activity ensures good monitoring, however, and an
increase in the spread of HIV in this group would probably be discovered quickly.
Hepatitis
Since 1995, we have observed an increase in the incidence of hepatitis A and B among drug users.
This has coincided with a significant increase in the reported number of new intravenous users since
1995. During the nationwide outbreak of hepatitis A from 1995 to 2000, 1,360 drug users with
acute hepatitis A infection were identified. Only two cases were reported in 2002. The hepatitis B
outbreak continued into 2002, when 120 of a total of 183 cases of acute hepatitis B were among
injecting drug users. In the period 1995-2002 the total number of reported cases of acute hepatitis
B among injecting users was 1,417. 
The high incidence of hepatitis B among drug users has resulted in increased sexual transmission,
often to younger women in the drug user milieus. The outbreaks have illustrated the fact that intra-
venous use is no longer limited to cities and large towns, but has spread to smaller municipalities all
over the country. The outbreaks have led to free hepatitis A vaccine being offered to all drug users
in Norway since 2000. Hepatitis B vaccine has been offered free to drug users since 1984.
In Oslo small-scale prevalence surveys have been conducted in recent years, including one on hep-
atitis among drug users visiting the needle bus. In 2002 the survey showed that 60% of the 410
drug users examined had experienced a hepatitis A infection, 53% a hepatitis B-infection and 79%
a hepatitis C infection. In Norway hepatitis C is not monitored to the same extent as hepatitis A and
B, and hence the number of newly infected victims of the hepatitis C virus among drug users is
unknown. These Oslo surveys are the only regular prevalence surveys conducted among drug users
in Norway. In connection with these annual prevalence surveys, drug users are also offered x-ray
examinations to detect tuberculosis and vaccination against hepatitis A and B (NIPH). 
Other infections among drug users
Syphilis, gonorrhoea and other sexually transmitted diseases are rarely reported among drug users
in Norway. No outbreaks of tuberculosis have been registered among drug users in Norway. For sev-
eral years, the City of Oslo has conducted regular x-ray examinations among drug users, and there
are no signs that drug users in Norway are a risk group with respect to contracting tuberculosis. In
the last five years, four sporadic cases of wound botulism have been diagnosed among drug users
in Norway. The world’s first known case of systemic anthrax transferred through intravenous drug
use was diagnosed in Oslo in the spring of 2000. This was an isolated case, and it is assumed that
the heroin had been contaminated by anthrax bacteria in the country where it was produced. Skin
infections and abscesses are not uncommon among drug users. In some cases they may become
seriously septic/ toxic. Bacterial endocarditis is a well-known consequence of injecting. Every year a
small number of cases of such infections among drug users is reported, but it is clear that many such
infections are under-reported in reports to the Reporting system for infectious diseases (NIPH).  
3.4 Other drug-related morbidity
Co-morbidity is dealt with in chapter 16.
3.4.1 Drugs and driving
Statistics relating to driving under the influence of intoxicants have been monitored by the forensic
toxicology and drugs and alcohol research division at NIPH (formerly the National Forensic Toxicology
Institute - SRI) for many years.
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In the period 1990-2002 the number of cases in which the police suspected drivers of being under
the influence of alcohol had stabilised at around 5,500 cases per year. The biggest change was in
the number of cases in which the driver was suspected of being under the influence of intoxicants
other than alcohol and medicinal drugs. I 2002 the number of such cases (5,161) was almost as high
as for alcohol (5,486). The trend from 1990 to 2002 shows: 
• A gradual increase in the number of cases over the last 11 years. 
• However, the increase from 2001 to 2002 is much greater than any previously recorded – almost
20%. 
• Benzodiazepines (tranquilizers and sleeping pills) are the most frequently found substances in
these cases. Flunitrazepam, the active agent in Rohypnol, has increased dramatically (a doubling
in the last year). In 2002, flunitrazepam was the most frequently detected substance.
• There has also been a big increase in amphetamines – approx. 25%. 
• Methadone shows a strong increase, even if the absolute figures are much lower. 
• On average between two and three substances are found in each sample. 
• Intoxicants or medicinal drugs are found in almost 80% of the cases in which the police require
drivers to take blood tests.
• Norway is the leading country in Europe when it comes to catching drivers who are under the
influence of intoxicants. 
The distribution between cases in which the offender was suspected of being under the influence
of alcohol and cases in which the offender was suspected of being under the influence of other
intoxicants is shown in figure 10.
Figure 10.  Number of traffic cases investigated by SRI/NIPH in 1990-2002, in which being under the influence
of alcohol or other intoxicants was suspected.
Source:   NIPH
The detection of various narcotic substances is shown in table 4.
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Table  4.  Detection of various narcotic substances in traffic cases investigated by SRI/NIPH in 1990-2002
* Active agent in Valium, among others ** active agent in Rohypnol, among others *** chemical conversion
product of heroin
Source:  NIPH
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002  
Cannabis 564 627 842 741 660 995 708 1 027 1 502 1 504 1 686 1 732 1 886  
Diazepam* 430 475 676 541 577 712 744 928 1 004 910 808 1 050 1 113  
Flunitrazepam** 233 255 212 221 198 270 321 458 540 603 656 1 252 2 107  
Amphetamines 233 216 391 475 533 937 898 1 081 1 327 1 290 1 312 1 587 1 972  
Morphine 72 108 107 142 193 261 311 392 483 533 601 539 452  
6-MAM***  6 29 64 92 172 195 263 317 320 307 295 213  
Ecstasy MDMA)     0 6 23 27 67 123 194 194 180  
Cocaine     10 9 6 19 40 80 118 135 166  
Methadone           22 64 102  
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Chapter 4.  Social and Legal Correlates and Consequences
4.1 Social problems
Studies of Norwegian drug users show a major over-representation of various social problems. Many
live under very poor housing conditions, in environments with high crime, violence and prostitution.
A study of users of the needle bus in Oslo, for example, shows that more than 4/5 received welfare
or social security benefits, while only approximately 10% were in paid employment. Over half of the
women had earnings from prostitution (Bretteville-Jensen 2000). 
4.2 Drug offences and drug-related crime
Legislation
The Norwegian Penal Code section 162 and the Act on Medicinal Products section 31 (2), cf. sec-
tion 24 (1), regulate drug offences. The Penal Code regulates serious offences, while the Act on
Medicinal Products has provisions for what are considered less serious offences. In Norway, statistics
are kept for crimes reported, investigated, prosecuted and for convictions relating to drug offences.
However, information is not provided on the substances involved.
Table 5. No. of reported and investigated drug offences. 
Source: Crime statistics, SSB
Crime statistics (table 5) reveal a clear rise in drug-related crime. During the period 1991 to 2002
the number of violations of the Medicinal Products Act increased almost fivefold. The number of
arrests for violations of section 162 of the Penal Code, which regulates more serious drug crimes,
nearly tripled during the same period. Compared with other types of crime, the statistics covering
drug-related crime clearly show the sharpest increase. The high number of cases can, however, be
attributed to the fact that the same case may be registered as several violations if the person is
reported or investigated for both use, possession and purchase for his/ her own use. 
The number of persons charged for violation of drug laws has almost tripled from 1990 to 2002
(table 6). Statistics on the number of reactions against drug offences show a similarly sharp increase
(standard table 11).
Penal Code, section 162 Act on Medicinal Products Total   
Reported crimes Investigated crimes Reported crimes Investigated crimes Reported crimes Investigated crimes  
1991 7 377 5 328 5 711 4 621 13 088 9 949  
1992 7 692 6 250 6 328 5 059 14 020 11 309  
1993 7 640 6 458 6 432 5 281 14 072 11 739  
1994 8 005 6 458 6 759 5 384 14 764 11 842  
1995 11 911 8 044 11 420 7 629 23 331 15 673  
1996 13 669 10 310 13 786 10 442 27 455 20 752  
1997 16 169 11 639 18 376 12 360 34 545 23 999  
1998 17 276 13 809 21 498 16 489 38 774 30 298  
1999 17 820 16 041 23 167 20 135 40 987 36 176  
2000 19 302 16 718 24 726 21 574 44 028 38 292  
2001 21 411 18 667 27 548 25 073 48 959 43 740  
2002 20 600  26 410  47 010   
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Table 6. Number of persons charged with drug crimes
Source: Crime statistics, Statistics Norway
4.3 Social and economic costs of drug consumption
a) In general it is always difficult to estimate the social costs of drug use. As regards the economic
costs for municipalities, SIRUS carried out a study in 2003 on “Intoxication and psychiatry in the
municipalities’ income systems”, commissioned by the Ministry of Local Government and Regional
Development. 
Among the most important direct costs for municipalities are the municipalities’ own share of treat-
ments costs and the cost of work directly among drug and alcohol users (outreach workers etc.). In
total Norwegian municipalities spent approx. EUR 63 million4 on this work in 2001 (net)5. There are
no corresponding figures relating to how much money the municipalities spent on mental health-
care, but there is reason to believe that municipal expenditure is moderate – both because the
municipalities do not pay an own share for psychiatric treatment and because the funds allocated
by central government for stepping up psychiatric healthcare cover many of the municipalities’
expenses.
In addition to direct costs relating to drugs and alcohol and psychiatry, there are indirect costs, of
which social security and child welfare expenditure stand out as particularly important. On the basis
of user surveys we can assume that roughly 23% of social security expenditure is spent on persons
with alcohol and drug problems.  Estimates based on these surveys show that the total municipal
expenditure on drugs and alcohol abusers is at least EUR 275 million. This is a relatively small share
of total municipal operating expenditure, but there are great variations between the different
municipalities (SIRUS report no. 3, 2003). 
b) Central government expenditure on preventive measures and treatment of drug and alcohol
abusers was described  in chapter 14 of the National Report for 2002. An overview of central gov-
ernment grants in 2003 is provided in  chapters 1.4 , 9 d) and 10.1. 
Penal Code, Act on Medicinal Total
s. 162 Products
1991 1 584 1 993 3 577  
1992 1 974 1 929 3 903  
1993 2 282 1 508 3 790  
1994 2 143 1 303 3 446  
1995 2 496 1 442 3 938  
1996 2 878 1 577 4 455  
1997 3 424 1 764 5 188  
1998 4 056 2 430 6 486  
1999 4 891 3 111 8 002  
2000 5 539 3 651 9 190  
2001 6 287 4 459 10 746  
4 Exchange rate used: 1 Euro = 8 NOK
5 Includes users of all types of intoxicants, both alcohol and narcotic substances.
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Chapter 5.  Drug Markets
5.1 Availability and supply
The seizures made by the police and customs authorities of different substances in recent years are
a clear indication that use and abuse of the various narcotic substances increasingly takes place in
all parts of the country. Seizures of cannabis, amphetamines/ metamphetamines and benzodi-
azepines have been made in all 27 police districts, cocaine in 24 districts, heroin in 23 districts and
ecstasy in 25 districts (NCIS’ six-monthly report 2003). 
Together with data from the survey of some selected municipalities (chapter 2.2 ), this is a reliable
indication that drug use and drug dealing is increasingly spreading to small communities through-
out the country, even if the problem is still most preponderant in the cities and large towns. 
Surveys are another means of measuring changes in availability. The annual survey of young people
aged 15-20 shows, for example, that there has been an increase in the proportion of those stating
that they have been offered cannabis from approximately 25% during the first half of the 1990s, to
about 40% in recent years. Similarly, the proportion who state that they would be able to obtain
cannabis within 2-3 days has increased from about 55% to 65% during the same period. 
The increasing mortality rate confirms that the use of heroin is increasing throughout the country.
Even though the number of drug-related deaths dropped sharply in 2002, such deaths were regis-
tered in 23 of the 27 police districts. 
The narcotics section at Oslo police district estimates that approximately 80% of all drugs that are
smuggled into Norway are destined for Oslo and are spread to the rest of the country from there.
The trend is that drugs are spreading to more and more police districts. Drugs are often smuggled
through natural ports of entry such as the Swedish border crossings and ferry ports. New substances
largely arrive in Oslo and the central eastern part of the country first. Once a market has been estab-
lished for such drugs, they are then spread to other areas of Norway.
5.2 Seizures
NCIS registers drug seizures made by the police and customs authorities. In this way double regis-
tration is avoided in cases in which both the customs authority and the police are involved. The num-
ber of seizures is defined on the basis of the number of times a substance is detected and is quan-
tified by different types of substances, the time of seizure and how it was carried out. In other
words, multiple seizures are registered for one and the same case if different types of substances are
confiscated. The same holds true if the seizures are made in different locations or at different points
in time. 
Main trends in 2002
The number of drug cases reported to NCIS in 2002 once again showed a marked increase. The
number of drug seizures increased by approx. 10% compared with 2001, which was also a record
year. The trend is not unambiguous however. Benzodiazepines - of which Rohypnol constitutes 3/4,
and metamphetamines have increased most.  The increase is also great for medicinal pain killers clas-
sified as illicit narcotic drugs. 
It is also worth noting that the number of heroin seizures has dropped markedly, and we have to go
all the way back to 1995 to find the same frequency of seizures. The amounts seized were, howev-
er, relatively large.
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The number of cocaine seizures increased by 16%, and this can only be described as a marked
increase, even though the rate of increase has decreased slightly compared with recent years. 
For ecstasy, the number of big seizures increased considerably, while the total number of seizures
decreased by 14%.
Cannabis remains the most frequently seized drug. In 2002 cannabis accounted for approx. 1/3 of
all seizures, but the increase is smaller than in the last 5 years.
Seizures of GHB remain at a low level, on a par with what has been recorded during recent years.
It seems that its prevalence is very marginal compared with other drugs.
Based on the number of seizures, it appears that LSD has almost disappeared from the market.
Trends in 2003
NCIS’ figures for the first six months show a clear decrease in the number of drug cases and
seizures. The decrease in the number of seizures (17% compared with the same period in 2002)
applies to most substances, except LSD and GHB, and is particularly marked for ecstasy, benzo-
diazepines, cocaine and heroin.
On the other hand, there have been many big seizures of most types of drugs.  The quantities of
cannabis, heroin, amphetamines, metamphetamines, khat, ecstasy, benzodiazepines and LSD are
well above the average indicated in the six-monthly statistics in recent years. The number of
seizures of GHB during the first six months has already exceeded the number of seizures made
during the whole of 2002.
NCIS assume that the reduction in the number of seizures is related to the fact that the police
have given priority to investigating major drug cases and directed their efforts less at users and
the final link in the chain of distribution. 
While the increase in seizures of flunitrazepam (Rohypnol) was quite dramatic in 2002, there has
been a marked decrease in the first six months of 2003. 
This trend is confirmed by substance analyses in road traffic cases. In 2002, flunitrazepam was
the most frequently detected substance. The trend in 2003 shows a decrease during the first six
months. The decrease may be due to the fact that illegal importation from Eastern Europe has
been considerably reduced.
The tables, figures and text included in the following relate to 2002 (standard table 13).  
33
N A T I O N A L  R E P O R T  2 0 0 3  –  S I R U S
Figure 11. Number of drug seizures 1995 – 2002
Source: NCIS
Table 7. Number of seizures 2000 – 2002, broken down by the most common substances
Source: NCIS
Cannabis
In 2002 seizures of cannabis totalled 1,221 kg. This is well above the average for the last ten years.
Only three times previously has a greater quantity been seized in a single year. The number of
seizures increase marginally compared with 2001. Hash accounts for more than 85% of the total
number of cannabis seizures. 
Most of the cannabis that reaches the Norwegian market is produced in North Africa. It is often
transported via Spain, the Netherlands and Denmark to Norway. There are many players involved –
both in the importation and at the receiving end, and the importation cannot be tied to any partic-
ular ethnic group. In most cases importation and reception is carried out by Norwegians.
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Substance 2000 2001 2002 Change in% 
from 2001  
Cannabis 9 224 10 844 10 921 +0.7%  
Amphetamines 3 077 4 596 5 035 +9.6%  
Methamphetamines 173 392 695 +77.3%  
Heroin 2 314 2 501 1 906 -23.8%  
Benzodiazepines 4 265 6 024 8 056 +33.7%  
Pain killers 845 1 009 1 237 +22.6%  
Doping 469 643 697 +8.4%  
Cocaine 390 496 577 +16.3%  
Ecstasy 827 837 716 -14.5%  
Khat 255 198 238 +20.2%  
LSD 87 52 15 -71.5%  
GHB 83 82 75 -8.5%  
Opium 19 24 14 -41.7%  
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Amphetamines/ metamphetamines
The quantities of amphetamines and metamphetamines seized in 2002 were 209 kg and 23.6 kg,
respectively, divided between 5,035 and 695 seizures. The quantities seized have almost trebled
compared with the average for the last ten years, and the number of seizures has increased by
133% in five years.
Ten years ago there were far more seizures of heroin than amphetamines. In 1998 the number of
seizures was the same for both these substances, while in 2002 the frequency of seizures was three
times higher for amphetamines and metamphetamines than for heroin. 
The average purity of seizures of more than 15 grams is estimated to be approx. 34%. This is sig-
nificantly less pure than in 2001, when the average purity was 42%.
Most of the amphetamines seized in Norway are produced in Europe and mainly originate in the
Netherlands, Belgium, Poland and Estonia. Most of the metamphetamines that are seized are pro-
duced in the Baltic countries and imported by criminal groups of Baltic origin. 
Heroin
A total of approx. 59.1 kg heroin was seized in 2002. Only in two previous years have the quanti-
ties seized been greater. There has been a marked drop in the number of seizures for the country
as a whole, however, including Oslo. This trend was particularly marked in the last six months of the
year. The number of seizures fell by 13% in Oslo, and by as much as 24% at the national level.
The average amount of heroin in the substance mix has been estimated at approx. 30% weight,
which represents the lowest purity registered in any one year. It is worth noting that the purity was
the same for large seizures as for the smallest seizures for the second year running.
Ecstasy
The number of “ecstasy” tablets seized in 2002 was 102,433. In addition, 75 g of powder con-
taining ecstasy was seized. The quantity has never been this high before, and the increase on 2001
is marked. The number of seizures was only 716, however, and this is a decrease of approx. 14%.
There is reason to believe that this has to do with the fact that there were many large individual
seizures. MDMA dominates the market and was detected in 99.6% of the seizures. Only four
seizures have been recorded for the substances MDA, PMA and MDEA. 
Neither 2C-B, DOB, 2C-J, 2C-T-2 or other known hallucinogenic substances were detected in the
seizures made in 2002.
New tablets are received nearly every week, and a total of 47 new logos were registered in 2002,
of which three turned out not to contain ecstasy. Compared with 2001, the supply of new tablets/
logos fell by about 25%. 
”Ecstasy” tablets are produced illegally and are therefore not subject to quality control like com-
mercial medicinal products. Nor is there any declaration of contents in connection with the distri-
bution of the tablets. Despite this, very few deviations from the "norm" have been registered dur-
ing the last 15 years; the great majority of tablets contain between 70 and 120 mg of the active
agent (MDMA). So far, opioids have not been detected in any of the tablet seizures.
Benzodiazepines
Throughout the country, the benzodiazepine group of substances has increased more than any
other, both in terms of quantities and number of seizures. In 2002 the quantity seized was
1,251,100 tablets (an increase of 50% on 2001) in a total of 8,000 seizures (an increase of 33% on
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2001). At present, benzodiazepines account for approx. one quarter of the total number of seizures
in Norway. The number of seizures and the quantities seized have increased manifold in the course
of just a few years.
Rohypnol is the predominant substance, its share having risen from 60% to 76% in two years. Other
frequently seized benzodiazepines are Valium, Rivotril and Sobril. Benzodiazepines are very often
registered together with other substances (heroin, amphetamines, cannabis and ecstasy) in one and
the same drug case. The great majority of cases concern drugs that have been smuggled into the
country. 
Cocaine
In 2002 a total of 35.8 kg cocaine was seized in a total of 577 seizures. This quantity was only
exceeded in 1998 (due to one big seizure of drugs found in the sea) and 1999. 
In general, large quantities of cocaine are smuggled into Europe from South America, with Spain
being regarded as the main route of entry. However, the number of seizures in Spain fell compared
with the two preceding years. 
In the last two years the amount of cocaine in the powder seized has also been much lower on aver-
age than that registered in several decades. The purity of cocaine used to be more than 80%, while
the average for 2002 is estimated at 51%.
Other substances
Khat
The amount of khat seized decreased for the third year running. The number of seizures in 2002
(238) was, however, much higher than in 2001 (198). 
LSD
There was a marked decrease in both the quantity and number of seizures. 
GHB
Seizures of GHB remain at a low level in line with what has been registered during recent years.
Opium
There was a marked decrease in both the quantity and number of seizures compared with recent
years. 
Other opioids (medicinal pain killers classified as narcotic drugs)
Both the quantity and number of seizures of substances in this medicinal product category increased
markedly in 2002. A total of 70,000 medicinal doses were seized in a total of 1200 seizures. One
single seizure of Temgesic consisted of as much as 50,000 tablets. It is also worth noting that there
was a relatively large increase in the number of seizures of drugs containing methadone, which com-
prised 1,720 medicinal units divided between 65 seizures of methadone solution. In the course of
three years the number of methadone seizures has trebled and the quantity seized has increased
manifold. (NCIS)
5.3 Prices 
The prices reported for different narcotic substances are based on information obtained from the
narcotics section in the Oslo police district. The prices of the different narcotic substances vary
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according to the quantity being sold, so that the price per gram will be cheaper if one gram is
bought than if individual doses are bought. Prices for small quantities of cannabis have remained
stable over the last year, but the price for larger quantities (1 kg) has fallen significantly. The price
of heroin remains stable following a marked price fall during the previous five-year period. There are
minor changes as regards amphetamines, while ecstasy (MDMA) prices have been cut by almost half
for large purchases (per 100 tablets).
Table 8. Prices for some drugs in Oslo (January 2003). In Euros. Exchange rate: EUR 1= NOK 8.00  
Source: Oslo Police District
The “price list” is based on information from users and dealers at different levels, as well as infor-
mation received from police officers working in the narcotics section. Prices can vary widely at times,
depending on quality, contacts and quantity. 
Price developments are also monitored in a study in Oslo on the price elasticity of narcotic sub-
stances. A price elasticity indicates how much the consumption of a product will vary as the result
of an increase in the price of that product. Many people have claimed that those addicted to nar-
cotics, particularly substances like heroin and amphetamines, will not be very sensitive to changes
in price. It has been argued that addiction leads the addict to use approximately the same amount
of the drug almost regardless of the price of the drug he or she uses. The results of the data gath-
ered from intravenous drug users in Oslo indicate, however, that this is not correct. According to the
study, both heroin and amphetamine users will adjust their consumption significantly if the price of
the substance changes, and heroin abusers appear to be more price sensitive than amphetamine
users (Bretteville-Jensen and Biørn 2002). The material also suggests that women are more price
sensitive than men (Bretteville-Jensen 1999). 
Type of substance Dealer doses 1 gram 10 grams 1 kilo  
Heroin 0.1 g/19-25, 0.2 g/38-50   100-150  750-250  31,250-62,500   
Hash  12.5 (0.5-0.7 g) - 75-100 1,750-4,375  
Amphetamine 19-25 (0.2 g) 25-50 250-625 7,500-11,250  
Ecstasy 12.5-19 per tablet  6-7.5 per tablet (100) 3-4 per tablet (1000)  
Cocaine ca. 20 lines per gr.  ca. 31  750 – 1,250 37,500 – 75,000  
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Chapter 6. Trends per drug
Cannabis
There has been an increase in the use of cannabis in the course of the last decade. This is evident
from, among other things, surveys and analyses of blood samples taken from drivers suspected of
driving under the influence. The number of seizures has also increased, particularly in the last four
years. The price of cannabis has remained relatively stable in the same period. The fact that cannabis
has become more available on the Norwegian market is also illustrated by survey data in that an
increasing proportion of the respondents state that they have been offered cannabis or would be
able to get hold of cannabis should they want to use it. 
Synthetic substances
Amphetamines are either injected or taken orally. Even though amphetamines have not been as pre-
dominant among intravenous drug users in Norway as, for instance, in our neighbouring country
Sweden, amphetamines have been used extensively by established drug abusers, and particularly so
outside the Oslo area. Together with ecstasy the use of amphetamines is part of the drug culture
partly associated with the ”house” scene in the cities and large towns, and these substances are
also a part of the party culture in some youth subcultures. Various data sources, such as seizures,
surveys and drivers testing positive for ecstasy and amphetamines, indicate that the use of synthet-
ic substances has increased and become more prevalent.
Heroin/opiates
Estimates indicate that the number of intravenous drug users has doubled during the last decade.
Most of them inject heroin. Even though the number of drug fatalities decreased considerably in
2002, it remains high. More heroin is being seized throughout the country. The number of heroin
seizures has dropped significantly since 2002, however. Even though it is difficult to read changes
in use directly from the seizure figures for one single year, they seem to indicate a positive trend as
regards the use of heroin. It must also be assumed that the now considerable number of people
undergoing substitution treatment has somewhat reduced the demand for heroin. 
Cocaine/ crack
The survey data do not indicate that cocaine is widely used. There has been an increase in the num-
ber of seizures, however, and even if cocaine seems to be infrequent among drug abusers, it is
reported that cocaine, like ecstasy and amphetamines, has increasingly become part of the party cul-
ture in certain milieus. We do not know of any crack use in Norway.
Multiple use
Data from research on treatment and clinical reports indicate that most drug abusers are multiple
users. Alcohol is usually part of the picture, either in combination or alternating with other sub-
stances. The extensive use of other narcotic substances in addition to heroin is one of the big prob-
lems in connection with medically assisted rehabilitation.
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Chapter 7. Discussion
7.1 Consistency between indicators
There is consistency between the indicators, but some degree of uncertainty attached to the inter-
pretation of the different indicators relating to the development of drug use in Norway. In the long-
term perspective, there has been a consistent increase in the number of seizures, the number of
drug offences, the proportion of the population that has tried different substances etc.
Developments for ecstasy are a possible exception. In 2002 the number of seizures increased for all
substances, with the exception of heroin and ecstasy. The quantities seized increased for these sub-
stances too, however. The price level, on the other hand, has remained relatively stable, which does
not clearly point to an increase in availability. This is supported by the fact that the proportion of
young people aged 15-20 who report having ever used narcotic substances has actually fallen in the
last two or three years. 
7.2 Methodological limitations and data quality
For Norway's part, several of the indicators provided by the EMCDDA are still inadequate. This
applies in particular to data on clients undergoing treatment and estimates of heavy drug use. As
far as drug-related fatalities are concerned, the data based on the ICD-10 classification have been
updated for previous years. Norwegian reporting on those arrested for drug offences, intravenous
drug users with hepatitis, HIV and AIDS deviates from the guidelines provided. This is due to spe-
cific national procedures for reporting this type of information. 
The data on prevalence of drug use may also be somewhat unreliable. For example, a low response
rate in the annual youth surveys means that they are not representative. The illegal nature of the
different substances might also contribute to statistical underreporting. Moreover, young respon-
dents might have fewer qualms about providing information about their drug use than older
respondents, thereby contributing to a higher reporting rate for younger than older respondents.
Estimates of the number of intravenous drug users have been made using a multiplication method
based on registers of the number of drug fatalities. This method is based on there being a relation-
ship between the number of drug fatalities and the number of users. One source of bias here could
be that the figures for drug-related fatalities are not as reliable as they are assumed to be. Among
other methods, the estimates are based on drug fatalities registered by NCIS. There may, however,
sometimes be reason to question the grounds on which the police register a death as a drug fatal-
ity. Some cases might have been mistakenly defined as drug fatalities because the person was a drug
user even though the individual died of other causes. SIRUS is in the process of developing several
methods to provide better estimates of problematic heavy drug use. 
Drug offences are "victimless crimes" and are seldom reported by others. The number of crimes that
are investigated and lead to convictions is therefore largely dependent upon the efforts of the police
and customs authorities. Changes from one year to the next or variations between different districts
are therefore entirely, or at least partly, attributable to differences in the intensity of control activity,
without there necessarily being any difference in the number of crimes committed.
Seizures of drugs, both the number and volume confiscated, vary according to the priorities and
efforts of the police and customs authorities. Among other things, the seizure figures tell us very lit-
tle about the actual volume of substances that reach the market and are illegally used. The figures
for seizures can also be influenced by legislative changes. 
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PART III: Demand reduction interventions
Chapter 8. Strategies in Demand Reduction at National Level
8.1 Major strategies and activities
In Norway, little distinction is made between alcohol, medicinal drugs and narcotic drugs within the
prevention and treatment field. This is reflected in the action plans and strategies over the last 15-
20 years and in the implementation of preventive measures as well as treatment. 
The Government’s new Action plan to combat alcohol and drug problems (2003-2005) outlines
three strategically important goals for a policy on drugs and alcohol: 
1.  Prevention of all forms of alcohol and drug abuse, with particular focus on preventive 
work among children and young people
2.  Improved availability of efficient advisory services, help and treatment for persons with 
drug problems and their families
3.  Significant reduction in the incidence of drug-related damage to health and the number 
of drug-related fatalities.
The Government aims at establishing a low threshold for receiving help, and a high threshold for
discontinuing such help. The main objective is to considerably reduce the harmful health and social
effects of drug abuse. The action plan points out that in the field of alcohol and drug prevention,
parents, local neighbourhoods, voluntary organisations, municipal, county and state agencies must
constitute a chain of measures that compliment one another. There must be particular emphasis on
measures that address the greatest needs and most dire situations, and areas where measures have
been documented to have the best effect.
The Government points out that the interventions used must knowledge-based and constitute cost-
effective ways of attaining the goals. It will be important to ensure that all interventions carried out
by the public sector, or with public funding and approval, comply with specific quality criteria. This
requires, among other things, that the interventions are evaluated and that the evaluation is such
that both the short and long-term effects of the interventions are made clear. The evaluation should
be based on clear, universal criteria, including a shared understanding of what constitutes good pre-
vention and successful treatment. 
The Government will establish a system for follow-up whereby new and existing measures are struc-
tured on the basis of the new goal and instrument structure. There will be requirements for clearly
defined targets, target groups and measurement criteria, and for a planned evaluation to be imple-
mented concurrently with the intervention itself. 
Two expert advisory committees were appointed in 2003 – one on alcohol and one on drugs. They
focus on a user perspective because the Government considers it important that also families/ other
care personnel and former drug users participate in the committees with their first-hand knowledge
and experience. The committees are to provide the Government with ongoing advice about specif-
ic drug policy challenges, evaluate interventions, propose new ones and stimulate the development
of more knowledge.
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8.2 Approaches and new developments
8.2. a) New, innovative approaches
The Government’s action plan outlines a pilot project to ”develop targeted and coordinated pre-
ventive efforts at the municipal level”. The project has three cornerstones: procurement of the rele-
vant local data; broad, coordinated development and implementation of intervention measures; and
evaluation. The project is innovative in that it is inter-sectorial. The work will cut across the bound-
aries between the different administrative and organisational levels, and public and voluntary efforts
will be combined.  The pilot project will be evaluated by SIRUS.
8.2. b) Socio-cultural developments relevant to the reduction of demand
The traditional view of how a drug career starts is that smoking hashish gradually evolves into exper-
iments with other, harder drugs, of which amphetamines/ecstasy are currently the most likely.
Qualitative data give some indication that this picture may be about to change. New drug career
patterns may emerge, in which ecstasy or amphetamines are the door openers to illicit drug use,
even if this tendency is not as yet confirmed by quantitative studies. 
In several youth subcultures, there appears to be a tendency for drugs which have long been linked
to a specific youth subculture to now also be adopted by other groups, and thereby become
detached to some extent from their original cultural context.  
It is a reasonable assumption that all these spectacular trans-national youth cultures are innovative
at the outset (often inspired by movements in other countries), only to end up as a part of the big
popular culture landscape to which the majority of young people belong (mainstream position).
How this takes place and what happens to the drugs associated with these cultures is less certain.
We do know that ecstasy, for example, like cannabis, does not seem to disappear along with the
youth culture which introduced it (Mushuus G; Rossow I; Vestel V. 2002).
8.2. c) Public opinion
Public opinion on drugs can be said to be largely stable. Very generally speaking it can be said that
the vast majority of the population condemn, and do not use, narcotic substances. The same major-
ity has a correspondingly positive attitude to, and uses, alcohol.
The mass media play a pivotal role in maintaining this picture. The media’s presentation of alcohol
and narcotic substances is completely different in many respects: The choice of focus, degree of
problematisation and use of value-loaded words etc. help to create a picture of narcotic substances
as a major and grave problem, while alcohol is most often presented outside of a corresponding
problematic context (Norwegian official reports – NOU 2003:4). 
8.2. d) New research
In September 2001 the “Research commission on the knowledge base for drug and alcohol policy”
was appointed by the former Ministry of Health and Social Affairs, its terms of reference being to
provide knowledge that would serve to enhance the scientific basis for decision-making in the area
of drugs and alcohol. The commission submitted its report to the Ministry of Social Affairs in
February 2003.
The commission employed two strategies for collecting relevant knowledge on topics relating to the
prevention and treatment of drug and alcohol problems. 
1. Searching the literature for systematic outline articles of a certain quality published in the English
language, and a Swedish and a Scottish summary dealing with the relevant topics. 
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2. In order to obtain more detailed material concerning national data, all the relevant Norwegian
milieus were contacted, so that the commission could gain access to reports/ publications from the
period since 1980 that contained evaluations of  measures. (Norwegian official reports - NOU
2003:4). 
Its conclusions are discussed in chapter 9.1 d) Evaluation studies and results.
8.2. e) Specific events
No specific events to report.
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Chapter 9.  Prevention
9. a) National Strategy
The government’s action plan (2003-2005) divides preventive measures into two types of compli-
mentary measures:
1.  Supply reduction, where efforts are aimed at influencing the production, distribution and sale of
different drugs, and where prohibition, regulation and control will be the most important means
employed.
2.  Demand reduction, aimed at influencing the purchase and use of drugs. The means of achiev-
ing this will consist of different forms of educational and attitude-building measures and other
preventive measures, as well as control measures such as taxes and regulation and control of use. 
Central elements of preventive work in Norway are based on:
• Viewing prevention and health-promotion as two inter-related aspects  
• Directing preventive measures at individuals and specific risk groups, as well as large population
groups 
• Taking a long-term view of prevention
• The municipalities have a central role in preventive work
• Broad mobilisation of various voluntary organisations.
9. b) Organisation and coordination of preventive efforts in Norway
The Ministry of Social Affairs has overall responsibility for drug issues, including preventive measures. 
The Directorate of Health and Social Affairs has been assigned responsibility for coordinating the
implementation of preventive strategies and interventions. 
The drugs and alcohol competence centres6 have been given the task of assisting in the implemen-
tation of drugs and alcohol policy by the Directorate of Health and Social Affairs. Each competence
centre has one or more speciality areas in which it is expert and about which it has a national respon-
sibility for disseminating knowledge. The competence centres have an important role in cooperat-
ing with the municipalities in their regions to develop competence, methods and interventions in
the prevention field.
6 The competence centres have the following speciality areas:
REGION NORD (NORTHERN NORWAY): Counties: Nordland, Troms and Finnmark 
• Nordland's Clinic – www.nordlandsklinikken.no Speciality area: Group therapy approach to drugs and alco-
hol problems
REGION MIDT-NORGE  (CENTRAL NORWAY) Counties: Nord- og Sør-Trøndelag, Møre og Romsdal 
• Central Norway competence centre for alcohol and drugs – www.mnk-rus.no Speciality area: Youth and
drug use, young drug addicts
REGION VEST (WESTERN NORWAY) Counties: Sogn og fjordane, Hordaland and Rogaland 
• Rogaland A-centre - www.rogaland-asenter.no Speciality areas: Families and children of school age, alcohol
and drugs in the workplace 
• The Bergen Clinics Foundation – www.bergenclinics.hl.no Speciality area: Women and drugs and addiction,
female drug addicts
REGION ØST (EASTERN NORWAY) Counties: Oppland, Hedemark, Akershus and Østfold 
• Sanderud Hospital, Drug addiction ward – www.sanderud-sykehus.no Specialty area: Double diagnoses –
psychiatry and drugs, gambling addiction
REGION OSLO. 
• Alcohol and drug addiction service – City of Oslo - www.rusmiddeletaten.oslo.kommune.no Specialty areas:
New trends of use among young people
REGION SØR (SOUTHERN NORWAY) Counties: Aust-Agder and Vest-Agder, Telemark, Buskerud and Vestfold 
• Borgestad Clinic – www.borgestadklinikken.no Specialty areas: Pregnant addicts and addicts with small 
children.
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Prevention of drug and alcohol abuse is otherwise a municipal responsibility as set out in the Act on
social services. Municipal social services shall work to prevent and combat the use of alcohol and
other drugs through information and outreach services and spread information on the harmful
effects of such use. Drug prevention work shall mainly focus on local measures, emphasising the
interplay between home, school, the social and health sectors and the leisure and cultural sectors.
The goal is to achieve coordinated and inter-disciplinary efforts. 
How the work is organised is up to the individual municipality. In most municipalities responsibility
lies with the social services, but some of the bigger municipalities have elected to establish dedicat-
ed positions for the coordination of crime and drug prevention efforts. The aim is to strengthen pre-
ventive work by making it easier to coordinate the efforts of the different services and sectors.
Building on the idea that coordination of efforts can be cost effective, and that youth milieus and
drug milieus cut across municipal boundaries, inter-municipal cooperation on drugs has been initi-
ated in some areas. 
In addition to the public sector, voluntary organisations engaged in the drugs and alcohol field play
an important role in preventive work. These organisations have their own rules and guidelines for
the activities that they run.  The Directorate of Health and Social Affairs has a grant scheme, under
which voluntary organisations can apply for funding for their projects.
9. c) Overview of central government funding for preventive work
In 2003 the Directorate of Health and Social Affairs allocated a total of EUR 7,454,0007 to the seven
competence centres on drug-related issues. The allocations are meant to cover expenses relating to
day-to-day operation and the development of interventions.
The Directorate of Health and Social Affairs administers four grant schemes for preventive work,
from which funding can be applied for according to specific guidelines. Grant schemes and avail-
able funds for distribution in 2003:
1.  ”Grants for alcohol-free establishments providing overnight accommodation etc.” : EUR 469,500
2.  ”Grants to the Norwegian centre for the development of drug-free milieus”: EUR 685,000
3.  ”Grants to voluntary organisations engaged in the drugs and alcohol field”: EUR 4,356,625
4.  ”Other grants” (deserving national/ regional measures aimed at the prevention of drugs and 
alcohol abuse): EUR 937,500. 
In addition EUR 725,000 was allocated to prevention work through the Norwegian Tripartite
Committee for the Prevention of Alcohol and Drug Problems in the Workplace (AKAN).
9.1 School programmes
9.1 a) Central guidelines/ specific action plans
Schools have long played a central role in preventive work. Education on alcohol and drugs is incor-
porated in the national curriculum plan, under which it should be integrated with other lessons
(National Curriculum Plan of 1997). The goal is to carry out active preventive work in elementary
and secondary schools in order to combat the use and abuse of alcohol and drugs. This is under-
lined in the government’s action plan (2003-05). The government wants ”knowledge-based drugs
and alcohol education in schools that focuses on the students’ social skills and ability to master sit-
uations and with active parent participation” as one of several measures to prevent drug use.
7 Exchange rate used: 1 Euro = 8 NOK
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There are currently a great number of so-called drug prevention programmes and measures aimed
at schools, but the quality of such measures is very variable. This year, therefore, the Directorate of
Health and Social Affairs initiated the development of a joint strategy for the coordination of drugs
and alcohol prevention efforts in schools, with clear recommendations with respect to what, on the
basis of scientific criteria, can be regarded as expedient and effective programmes. A committee has
been appointed to prepare the recommendation scheme. The committee consists of representatives
of the Directorate of Health and Social Affairs and the competence centres. The work is expected
to be completed in 2004.
9.1. b) Models/ principles for school programmes
The committee preparing the recommendation scheme will emphasise programmes and interven-
tions that have a documented effect and/or are based on research-based principles. Central ele-
ments will include efforts over time, ensuring support from those in charge of schools, all-inclusive
and coordinated efforts by those involved, cooperation between home and school, parent involve-
ment, programmes which include or are designed to carry out process and results evaluations. 
9.1. c) Examples of school programmes/ interventions in schools 
Most of the school programmes currently in use focus on primary prevention. Some focus mainly on
tobacco and alcohol, others on social skills and mastering rather than on actual drug and alcohol
use. Only a few target youth at risk and/or have drug prevention as their main focus. The pro-
gramme concepts can provisionally be broken down as follows:
• Dialogue/ communication programmes in which issues and situations are described in a way that
enables the participants to reflect and communicate with others about these topics (”Youth and
drugs and alcohol”, ”Time breakers”, ”This year’s first-time users”, ”the Rainbow programme”
etc.) 
• Peer education; Peers (in this case youths) teach/ pass on knowledge to each other (”Dialogue
conferences”, ”Future” etc.)  
• Education programme/ guidance programmes (”Freezing point”, ”Local guide” etc.)
• Lifeskill training programme (“Lions Quest”, “Step by step”). (standard table 19: School 
programmes)
9.1. d) Evaluation studies and results
The Research Commission’s report on research in the area of drugs and alcohol, included an evalu-
ation of school programmes targeting children and adolescents. The commission divided the meas-
ures into two main types: didactic and interactive. In this context, “didactic measures” means dif-
ferent forms of classroom teaching in which the main emphasis is on adult “experts” conveying fac-
tual information to the students. The aim is to develop negative attitudes to drugs and alcohol, pre-
vent damage and postpone use. These programmes focus on the idea that sufficient knowledge will
result in correct behaviour. By “interactive measures” they mean educational schemes with partici-
pant involvement and in which the focus is on strengthening the students’ ability to make good
choices in difficult situations (mastering). 
The evaluation of drug-related measures is based on seven outline articles. Two of the articles are of
reasonably high quality, the remainder are of medium or poor quality. The results must therefore be
interpreted with some care. The number of primary studies is slightly less than 400, 90% of which
are from the USA. The results of this summary of knowledge relating to drug-related measures
show:
• that it is well-documented that school programmes increase the students’ level of knowledge
about drugs and the dangers of using them, while attitudes and behaviour are affected to a less-
er extent;
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• that it is well-documented that interactive programmes are more effective than didactic teaching
methods;
• that only short-term effects have been demonstrated, measured in terms of differences between
intervention and control groups, while good studies of high quality and with a long follow-up peri-
od are lacking;
• that the DARE (drug abuse resistance education) programme, whereby the police are brought in
to teach in the schools, is probably not expedient.
Only two of the Norwegian studies have result indicators that included drugs (attitudes and use).
They underpin the results of the international studies, particularly as regards the finding that inter-
active schemes can result in positive changes in behaviour in the short-term. But these studies have
a short follow-up time, and it has not been documented that any of the interventions that were
evaluated have an effect in the long term. There has been little investigation of undesirable side
effects.
The Research Commission concluded, therefore, that the primary effect of the programmes is on the
actual level of knowledge, while behaviour is less affected. Interactive programmes are more effec-
tive than didactic programmes, but these measures appears to have little effect in preventing drug
use among those groups that are at risk with respect to abuse (NOU 2003:4).
In 2001 the former Directorate for the Prevention of Alcohol and Drug Problems (now the
Directorate of Health and Social Affairs), ordered an external evaluation of the four grant schemes
for preventive measures relating to drugs and alcohol. A report was submitted in 2002 (NOR
Consulting AS). The evaluation started with an evaluation of objectives, regulations and awarding
practice, and went on to examine some individual projects to assess the products and effects that
the funding had resulted in. The main conclusion of the report was clear: The grant scheme as it
had been practised until then could not be said to promote the intention of stimulating efforts to
prevent drug and alcohol problems. The report made clear recommendations for changing practice.
In 2003, as a result of this evaluation, the Directorate of Health and Social Affairs started work on
changing the grant schemes.
9.1. e) Research projects
No new information is available concerning research into specific drug and alcohol abuse preven-
tion programmes/ interventions in schools in the current year. One expert group appointed by the
Ministry of Education and Research and the Ministry of Children and Family Affairs produced a
report in 2001: "Evaluation of programmes and measures to reduce problem behaviour and devel-
op social skills". 56 different programmes were evaluated but only 9 programmes were recom-
mended for use in schools. None of these was specifically related to drugs. Only one programme –
Dan Olweus's programme to combat bullying – was recommended without reservation. Eight other
programmes were evaluated as promising, but they all required further evaluation and, in part, fur-
ther development, before it could be ascertained whether they actually had the desired effect. The
report can be read at http://skolenettet.ls.no/sosial-kompetanse.
9.2 Youth programmes outside schools
9.2. a) Definitions
The criteria for being designated a youth intervention/ youth programme outside schools is that the
activity is not directed at students during school hours. Hence, measures linked to schools – such as
various programmes for parent involvement, though organised through schools, where the meet-
ings are held in school in the afternoons/ evenings, will belong in this group. 
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9.2. b) Types and descriptions of youth interventions outside schools 
At the end of the 1960s a system of public outreach services was established in a number of munic-
ipalities, and today there are 63 such services, covering most of the cities and large towns. They are
engaged in outreach work among children and young people. On average each unit has two-three
employees. The outreach service in Oslo is the biggest with 25 employees, all with professional qual-
ifications. Their activities encompass different preventive measures directed at older children and
youths, including contact with young people and helping those who have developed drug and alco-
hol abuse problems to get treatment. The project, "Stop the dope not the dancing" was initiated
in Oslo in 1995 as a collaboration between the outreach service in Oslo and young enthusiasts from
the house scene on an information campaign on drugs in the house and party scenes. The project
has changed its name to "Future" and is now found in four cities/ towns: Bergen, Trondheim,
Tønsberg and Oslo, as part of the activities of the outreach services.
”Future” targets young people aged 13-22 who are interested in/ belong to the rave/ techno/ trance
subcultures. The objective is: to create good norm transmitters in drug-free subcultures, prevent/
reduce the damaging effects of drugs, create alternatives that can compete with drugs and focus
on new trends and developments in this subculture.  The cornerstone principle of the project is
”youth-to-youth” contact. Young people (called dozers) work voluntarily in the projects in the dif-
ferent towns (standard table 21). 
Much of the municipal prevention work is based on various interventions/ programmes based
around schools: various parent and local community-based activities. Examples are:
”Time breakers” is a programme targeting adults with responsibility for children aged 6-12. It is a
communication programme intended to provide parents/ guardians with issues and descriptions of
situations that can be discussed, reflected on and raised with others.
”Parent cooperation on drug and alcohol prevention” is an intervention programme targeting par-
ents of 8th year students (lower secondary school). Parent meetings are organised around various
topics, the aim being to strengthen the bonds between parents and boost their authority to set lim-
its for their children’s experimentation with drugs and alcohol.
”This year’s first-time users” is based on a parents’ meeting of parents of 8th year students and
includes the use of a handbook to get parents to reflect on their own views on the topic. It is a dia-
logue-based programme, intended to get parents to talk to each other by dividing them into groups.
The focus is on communication – on using one’s own resources in cooperation with others (standard
table 19: School programmes).
A number of voluntary organisations engaged in the drugs and alcohol field run their own pro-
grammes and interventions/ measures aimed at young people outside schools with funding from the
Directorate for Health and Social Affairs.
9.2. c) Statistics and evaluation results
Føre Var (“Earlier warning system”) is a project, which was started in Bergen and Oslo in 2002 , to
further develop methods of collecting information on new trends and modes of use of narcotic sub-
stances among young people. The objective is to identify new and upcoming drug trends, provide
in-depth information in order to inform practitioners and politicians, increase the accuracy of polit-
ical interventions and increase the effectiveness and use of management by objectives in the prac-
tical field, update survey questionnaires and increase cooperation between different agencies. 
A report on the “Earlier warning system” in Bergen was published in June 2003, based on a com-
parison of information from autumn 2002 and spring 2003. It showed little change in availability
and use for the majority of the illicit drugs. It showed a flattening out and possible reduction in the
availability of Rohypnol during the period in question. There has been an increase in the use of ana-
bolic steroids in connection with body building. 
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9.2. d) Further education and training for professionals in the prevention field
Further education
There are 12 different training programmes within the drugs and alcohol field in Norway. All are uni-
versity college based, and most offer 20 credits (60 points). They aim to provide a general introduc-
tion to the drugs and alcohol field by covering the whole range of issues from early prevention to
treatment and after-care. 
Training in outreach work
The Alcohol and Drug Addiction Service’s competence centre in Oslo (RKS) is working to integrate
outreach work/ field work/ visiting services with the Service’s other professional training with a view
to developing national expertise in this area.
The work is based on the joint efforts of RKS, the National Association of Outreach Workers and the
City of Oslo’s outreach service and aims to: 
• Establish a two-semester course of training in outreach work in cooperation with a local universi-
ty college. The aim is a 30-credit course. 
• Intensify the work on a new textbook manuscript in this field. 
• Market an English “introductory book” on field work, such as (drug) prevention work among
young people. To be carried out in cooperation with the European Council’s Pompidou group 
• Initiate structured evaluation projects by different outreach services to make the work being done
more visible and identify success factors.
9.3 Family and childhood
9.3. a) Definitions
There is no shared, uniform and unequivocal definition of drug and alcohol prevention measures
aimed at families and children. But the government’s action plan emphasises that the situation of
children is a particularly important priority area, and the government wants to increase resources to
make it possible to intervene as early as possible. 
9.3. b) Types/ descriptions of interventions aimed at families and children
We know a lot about the consequences for children of living in families where there is substance
abuse. Studies have shown that the incidence of a number of problems is higher among the chil-
dren of substance abusers, and there are proven correlations between substance abuse in the home
and criminality during adolescence and adulthood (West & Pinz 1987, Miller & Jang 1977,
Christensen 1994). When these children grow up, they are also reported to suffer from psychoso-
matic problems, depression, eating disorders and borderline problems (Black et. al. 1986, Kashubeck
1994, Belliveau et. al. 1995).
The public duty to intervene on behalf of children living in families where there is substance abuse
and/or other forms of serious neglect is also regulated by law. Each municipality has a child welfare
service which, after an evaluation of what is best for the child (the Child Welfare Services Act sec-
tion 1), can if necessary remove the child from the family by force. The child welfare service also has
a preventive role, and shall provide help, support and guidance to families (long) before it becomes
necessary to take over daily care and control.
All municipalities have health clinics for children. They employ doctors and nurses and sometimes
also midwives. They carry out pregnancy checks and all newly-borns are invited to participate in a
vaccination programme stretching over two years, followed by a health check at the age of five.
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Many health clinics follow a practice of visiting the home soon after children are born. The health
clinics thus act as public bodies that reach most families with small children, and their personnel can
have an important role to play in the area of substance-abuse prevention.
On this basis the Borgestad clinic competence centre, whose special competence is "Pregnant
addicts and families with children”, has initiated a training programme aimed at health clinic
employees. The programme focuses on drugs and alcohol work in health clinics, with special
emphasis on increasing the employees’ ability to take action. This training programme will be con-
tinued next year.
Different voluntary organisations have also become involved in the issue of drugs and alcohol use
during pregnancy and parents' attitudes to drugs. Among others, the Blue Cross has developed a
programme called "Children in the danger zone", which aims to educate the network surrounding
children to recognise, understand and act when children suffer as a result of adult neglect. The pro-
gramme provides various services for local health clinics, kindergartens, primary and lower second-
ary schools as well as inter-sectorial co-operation. The message is directed at adults, but is about
children. 
Parents Against Drug Abuse is an organisation for drug users’ close family members. The objective
is to offer the families of drug users help to help themselves and to help the problem user back into
society. The organisation has around 60 local branches. They organise courses, seminars and meet-
ings and engage in individual support work.
9.3. c) Research projects and evaluation results
There are no recent results from major research projects in Norway in this area.
9.4 Other programmes
9.4. a) Regional and local strategies relevant to the regulation of the leisure sector. 
Many municipalities have drugs and alcohol policy action plans. These provide guidelines for local
drug-related work, in the areas of prevention, treatment and rehabilitation, and also outline local
drugs and alcohol policy strategies/ instruments relating to licences for serving alcohol, opening
hours for the sale and serving of alcohol etc.
9.4. b) Brief analysis of the framework for leisure-based activities
There are many players who run leisure-based facilities, even though there are no statutory require-
ments in this area. A number of municipal facilities exist, such as after-school clubs or activity hous-
es/ multi-use halls. The drug prevention effect of such facilities is at best indirect in that people who
might otherwise be adrift are ”caught” and offered meaningful activities. 
Voluntary organisations are most active in this area, however. They include various ideological (reli-
gious, humanitarian, political) associations/ organisations, various youth organisations, sports clubs
etc. Each organisation has its own objectives and rules. Some, such as ”Youth against drugs” and
the ”Association against drugs” have specific focus on drug prevention, but the vast majority do
not. Insofar as what they provide can be said to have a preventive intention (or effect), they also
qualify for inclusion in the category health-promoting activities.
9.4. c) Central framework for regulating licensed premises etc.
The most important regulatory mechanism relating to licensed premises is the ”Act on the sale of
alcoholic beverages etc. The Alcohol Act provides a framework that regulates the sale and serving
of alcohol, while the licensing authorities are the municipal councils. In cases of breach or non-ful-
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filment of requirements imposed on the licensee, their licence can be withdrawn. Note: A licence
can also be withdrawn in the case of repeated drug dealing on the licensed premises. 
9.4.d) Applicable guidelines for the leisure sector and how they are enforced.
There are no such formal guidelines or regulations.
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Chapter 10. Reduction of drug-related harm
10.1 New initiatives in 2003
In 2003 efforts to expand low threshold health services for heavy problem users have been intensi-
fied. The central government allocates EUR 5,250,0008 for such health measures in the municipali-
ties. This is an increase of EUR 1,750,000 compared with 2002. This year 27 municipalities will
receive funding for various measures, compared with 24 municipalities last year. Several of the
municipalities that have previously received support, now have the opportunity to extend and
strengthen the services offered. 
Low threshold health services target heavy problem users who are incapable of availing themselves
of the normal health services. Services include offering problem drug users health checks, vaccina-
tions, user equipment, protection against infectious diseases, guidance and follow-up after over-
doses. It has been demonstrated that such measures reach the most abject problem users. They are
also an important contribution in fighting overdose fatalities. In several municipalities low threshold
measures are integrated with other health services, such as the accident and emergency service and
ambulance service. New measures, including dental health measures and "street psychiatry support
measures", are being tried out. 
In Oslo an action plan has been drawn up to provide alternatives to the drug milieus in the city cen-
tre. The action plan was launched at the end of 2002 as a result of the work of a working group
consisting of representatives of the Ministry of Justice, the Ministry of Health, the Ministry of Social
Affairs, the Ministry of Children and Family Affairs, the Ministry of Local Government and Regional
Development, Oslo Police District and the Oslo’s Municipal Department for Welfare and Social
Services. The working group proposed measures intended to break up the drug abusing milieus in
the centre of Oslo in order to prevent the extensive drug dealing and reduce recruitment. 
These measures are aimed at achieving a more active rehabilitation of, and care for, the clients, so
that they as far as possible can be offered meaningful welfare services where they live and can stay
during the day. These measures also aim to provide alternative social milieus, so that the number of
drug abusers in the centre of Oslo will be reduced. Further interventions by the police and munici-
pal services will target new recruits to these milieus. 
The Ministry of Social Affairs has given the City of Oslo a grant of EUR 625,000 for three projects
under the action plan. The three projects are: 
• return to/ resettlement in the home municipality
• an extension of the residential training programme and follow-up
• referral from low threshold measures. 
These funds are additional to the previously mentioned grant schemes available to municipalities.
Moreover, in the budget for 2003 the Storting allocated EUR 500,000 to Oslo Police District, ear-
marked for following up the action plan. These funds are mainly being used to increase the man-
ning of the police unit at Oslo Central Station, in addition to following up the cooperation with the
City of Oslo and the Emergency Child Protection Service.
The implementation of the action plan will be evaluated by SIRUS. 
8 Exchange rate used: 1 Euro = 8 NOK
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10.2  Description of interventions
Needle distribution programmes
Since 1988 Oslo has had a bus doing the rounds of the streets, providing clean needles and con-
doms free of charge. The bus now distributes 2 million needles annually. Other large municipalities
also distribute needles, often using a combination of self-service dispensers, outreach services and
one or more low threshold points of contact, often in co-operation with the health services. This
service is first and foremost a disease prevention effort and has hopefully contributed to the low inci-
dence of HIV among drug users in Norway. The incidence of hepatitis continues to be high, how-
ever (see chapter 3.3.). In 2003 the needle distribution programme in Oslo was moved into perma-
nent premises alongside a low threshold health service (standard table 10).
Low threshold health measures
Those who are heavily addicted to drugs often have extensive health problems of both a mental and
somatic nature, but the ordinary health services have not managed to deal with these problems. This
is true of primary health-service physicians as well as hospitals. In 1999, so-called field nursing sta-
tions were established in Oslo, in connection with low threshold day shelters and institutions at six
locations in the city. These offer street level healthcare to out-patients. The intention is to provide
healthcare and healthcare information, register health problems and any needs for medical assis-
tance, provide rudimentary treatment for somatic problems and channel users into the established
health and social services. The programme is non-bureaucratic and free of charge to the users. Those
who wish to visit a field nursing station do so anonymously without an appointment, regardless of
whether they are under the influence of drugs or not. The field nursing stations in Oslo now have
about 2,000 clients. Similar programmes of varying scope have also emerged other places in
Norway, for example the Strax house in Bergen and the Social Medicine Centre in Tromsø.
Over the last four years the field nursing stations in Oslo, in association with the needle bus, have
run vaccination campaigns against hepatitis, and also completed a successful x-ray programme. 
A separate nutrition project has also been carried out at a rehabilitation centre in Oslo for women
with drug problems. It turned out that many of the women suffered from malnutrition or under-
nourishment. Greater emphasis on regular meals has proven to have a positive effect on their health.
Oslo has prepared an injection room, linked to the field nursing stations in the city centre. A politi-
cal decision on whether or not to put this room to use is pending (see chapter 1.1.)
Outreach work
Many of Norway's municipalities have a long tradition of outreach work targeting drug users. The
objective is partly to offer assistance and guidance to new recruits to the drug scene at an early
stage, and to help people get out of the drug milieus quickly. (See chapter 9.2. on outreach work).
Outreach services have also been established, more geared to addressing emergency situations,
making referrals and following up those at risk of overdosing. These services also carry out home
visits and drive people home or to a detoxification station. For example, in Oslo the Outreach and
Coordination Service (OKT) has access to mobile funds that can be used to help clients in need of
treatment or care to get assistance quickly, also in those cases where the municipality has no spare
capacity, but where there are openings elsewhere. In most cases the OKT cooperates closely with
the ambulance service when someone has overdosed, and it operates its own follow-up service for
clients who have survived an overdose.
The PRO Centre in Oslo is a competence centre that addresses the needs of street prostitutes, both
through outreach work and by providing a warm-up shelter. Other municipalities also run similar
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services. One of the six field nursing stations in Oslo is at the PRO Centre and it offers low thresh-
old health services to prostitutes. Similar measures are also found in other towns and cities.
The Alcohol and Drug Addiction Service in Oslo cooperates with the ambulance service to offer
courses in first aid, not only to active drug users in downtown Oslo, but also to the police, shop
workers, railway station security staff and persons manning the public toilets, café and restaurant
personnel and others who work daily or move in areas frequented by drug users. It is not known
how effective this is, but the number of overdose fatalities in the city centre has dropped signifi-
cantly in recent years.
10.3  Standards and evaluation
Most harm reduction programmes in Norway have been carried out without extensive scientific eval-
uation. As harm reduction programmes in Norway have become more goal-oriented, greater
emphasis has also been put on proper evaluation, although few long-term results are available as
yet. However, trial projects with methadone have been evaluated both in terms of the process and
client status. The field nursing stations in Oslo were evaluated after six months. The needle bus was
evaluated in 1997, and it has also formed the basis for several studies of the drug using communi-
ty. 
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Chapter 11. Treatment
The Ministry of Social Affairs has the chief responsibility for co-ordinating care and treatment. A
closer examination of how this is organised is provided in chapter 1.1.
Treatment is by and large voluntary, but pursuant to the Act on social services (section 6-2) drug
users can be held in an institution for up to three months on the decision of the County Social
Welfare Board. Individuals who are voluntary admitted can enter into an agreement to be held for
up to three weeks (section 6-3). The intention behind the use of compulsion is to motivate the client
for further treatment. 
Pursuant to the Act on social services (section 6-2 litera a), pregnant drug abusers can be admitted
to an institution and held there for the duration of their pregnancy, if their abuse is such that the
child, in all probability, would sustain congenital damage and voluntary measures are deemed insuf-
ficient. 
Section 6-2 litera a) is used actively by the social services when voluntary approaches are not possi-
ble. This authority can also be used 'passively' in the sense that it has a 'disciplinary' effect on preg-
nant drug users who are negative to all forms of intervention by the health services, but who will
nevertheless agree to voluntary measures when they learn about the social services' access to com-
pulsory detainment.
11.1 Drug-free treatment and healthcare
Drug-free treatment aimed at achieving a future drug-free existence is still the main approach
adopted in the majority of Norwegian treatment programmes. 
A wide array of treatment and care programmes has been developed in Norway based on different
professional and ideological approaches. Treatment alternatives vary from professional psychother-
apeutic approaches to simpler approaches in which acceptance of the Christian message plays a
central role. Psychiatric assistance to out-patients is offered by psychiatric clinics for children and
adolescents, open social medicine clinics, and psychiatric youth teams. Psychiatric outpatient clinics
for children and adolescents offer treatment to children and adolescents under the age of 18 for all
types of mental disorders and problems. There are approximately 70 psychiatric outpatient clinics for
children and adolescents and approximately 100 psychiatric outpatient clinics for adults across the
country. Some adult clinics employ personnel dedicated to working with drug and alcohol abusers
suffering from mental disorders. The psychiatric youth teams work especially with adolescents and
young adults between 15 and 30 years of age who have both drug problems and mental health
problems. Norway has 34 psychiatric youth teams. Instead of separate youth teams, four counties
have employed dedicated alcohol and drug personnel in the psychiatric clinics for adults. 
Institutions offering 24-hour services include everything from small institutions with few employees
and few clients to large institutions with several departments. Ownership varies: They may be
owned by the county, by public or private foundations, limited companies or be privately owned.
Approximately two-thirds of the 24-hour facilities available to alcohol and drug abusers are in pri-
vate hands. Hence organisations like the Church’s City Mission, the Pentecostal Church’s Evangelical
Centre, the Blue Cross and the Salvation Army, among others, represent a considerable supplement
to public institutional services.
Common to all these treatment alternatives is that they are generally open to problem users of alco-
hol, medicines and drugs alike and are mainly financed by public funds. 
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Emergency and detoxification institutions offer detoxification and motivation for admission to other
rehabilitation programmes. Emergency institutions may be units forming a part of treatment insti-
tutions or other facilities that focus on saving lives in a crisis.
In addition to the facilities described above, there are a number of care programmes for abject
abusers who have little potential for rehabilitation, offering them supervision and care in a drug-free
environment. Other such facilities include halfway houses, which aim to improve the residents' abil-
ity to master a “normal life”.
11.2 Research on treatment and evaluation
SIRUS is charged with the task of conducting and disseminating research and documentation on
drugs and alcohol issues, with particular emphasis on social-scientific issues. The institute's research
can be divided into five main areas: the drugs and alcohol market, drugs and alcohol use and drugs
and alcohol culture, preventive measures, consequences, treatment and care. 
SIRUS is responsible for the treatment study, "What benefit, for whom and at what cost? A prospec-
tive multi-centre study of the treatment of drug abusers". Co-operating partners in the study include
20 treatment programmes in Oslo and surrounding municipalities. The project is intended to evalu-
ate treatment approaches and different treatments for drug users to ascertain whether any of the
responses lead to better results than the rest for the various groups of drug users. The project is
organised as a prospective multi-centre study in which 482 clients from 4 different treatment cate-
gories were followed up over two years. The clients were interviewed using a structured survey (ASI)
to measure drug use and psychosocial status and they also completed three questionnaires (MCMI,
SCL-25, CTQ) themselves. Moreover, information is being collected relating to what the clients think
of their own drug abuse, and their evaluation of the treatment they have received and the follow-
up by the first line services. The clients are also asked to describe different “life events” after leav-
ing the recruitment programme. Information about resource consumption and accounts will be
obtained from the programmes, and questions asked about treatment ideology and structure. The
number of hours spent on the different treatment programmes for each client will also be registered.
Information will also be collected from different databases, such as the Criminal Records Register,
the National Insurance Administration, the Cause of Death Registry and Statistics Norway (various
social security payments, welfare support measures). 
The second and final follow-up of the 482 clients was concluded in July 2002. A very good response
rate was achieved in both follow-ups; 92% in the first follow-up and 88% in the second. 2.9% of
the sample (n=482) died before the first follow up, and 1.5% died before the second follow-up
(n=468), i.e. in the course of a two-year observation period. The average age of the clients admit-
ted for treatment was 31 years, and the proportion of women was 33%. 
So far, the project has made several interesting findings. When it comes to the benefit of the treat-
ment, the study shows that the average intake of drugs such as heroin and amphetamines was
halved following treatment. There were also clear improvements in other areas: the number of days
including criminal activity fell by 60%, and the number of days mental problems were experienced
was reduced by 20%. However, these average figures conceal large variations between the differ-
ent types of measures, in terms of both the extent of the change and the costs of the treatment.
The Psychiatric Youth Teams (PUT) were by far the cheapest treatment, in which an average of EUR
3,750 was spent per client. However, this treatment was also the least effective in reducing the
intake of heroin (7% reduction). On the other hand, the PUTs achieved the best mental health
improvements (40% improvement measured by the number of days with mental problems).
The treatment that on average produced the best results in terms of reduced use of heroin was med-
ically assisted rehabilitation (MAR) (reduction of 69%). But unlike the PUT clients, MAR clients
55
N A T I O N A L  R E P O R T  2 0 0 3  –  S I R U S
reported a considerable increase in the number of days with mental problems (85%). The average
spending on each MAR client was EUR 28,875 (slightly more than EUR 37.5 per client day).9
The improvement in terms of heroin intake in clients who have undergone traditional medication-
free treatment in residential facilities is almost as great as in MAR clients, and the results are better
in terms of mental health. The cost of treatment in such facilities is higher, however, averaging
around EUR 81,250 per client (approx. EUR 250 per treatment day). 
As expected, the most costly treatment in residential facilities was that for very young clients (aver-
age age 16 years) attending so-called youth facilities. Average expenditure here was EUR 187,000
per client. The period of treatment was also the longest, which explains the high costs. These clients
had almost no intake of heroin before admission, but there was a big reduction in their use of
cannabis. These clients had the biggest percentage reduction in days with criminal activity (88%).
All in all, the figures show that no type of treatment scores ”best” on all counts. MAR was, for
instance, best in terms of reducing the use of heroin, while the PUTs were best in terms of reducing
mental problems (SIRUS ).
11.3 Substitution and maintenance programmes
Medically assisted rehabilitation using methadone and other medication for heavy drug abusers has
been available nationally since 1998. National guidelines have been adopted, describing responsi-
bilities and the organisation of medically assisted rehabilitation at regional and national level. The
system is based on specialised regional centres, although the municipal health and social services are
responsible for follow-up. 
At present the system has been extended so that this type of assistance is offered in all municipali-
ties and counties.
Objectives
The objective is to provide assistance and treatment for heroin abuse and social and health prob-
lems. Everyone who satisfies the criteria is to be offered assistance in their home municipality. The
scheme aims to provide clients with adequate housing, an orderly life and orderly finances. It should
offer clients a sense of belonging and leisure pursuits outside the drug milieus. The use of medici-
nal drugs for intoxication purposes and the use of illicit drugs must stop. 
Criteria
The criteria for admission were revised in 2000 and made less restrictive: The applicants must be at
least 25 years old, heavily addicted to an opiate despite reasonably extensive treatment and have
several years of opiate addiction behind them. The criteria may be deviated from on the basis of an
overall evaluation of health and social problems. When methadone or another adequate medicinal
drug is necessary for treating serious illnesses, the criteria relating to age and previous treatment do
not apply. 
Availability and organisation
Clients apply for treatment themselves through their social services centre, possibly in cooperation
with their doctors or therapists in other programmes. The application must include a description of
their drug use and previous treatment. An action plan shall be prepared describing the existing prob-
lems and the cooperation planned to remedy them. It is also possible to apply for and start treat-
ment while in prison. The treatment can be initiated without application in a psychiatric or mental
institution after an evaluation by the responsible head doctor, but cannot be continued after dis-
9 Exchange rate 1 Euro= 8 NOK
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charge without an application being made. Doctors can also use opiate medicines for crisis inter-
vention and for clarification of assistance needs and an intervention plan.
The application shall be sent to and approved by the regional centre. The treatment starts under the
auspices of or in the regional centre with weaning from other drugs, the necessary examinations
and stepping up of medication.  Medication is prescribed by the centre or by doctors cooperating
with the centre.
Unless there are special requirements, the treatment will mainly be ambulant, the medication being
supplied by chemists or in a regional facility.  Admission may take place for weaning purposes, cri-
sis intervention or treatment of specific conditions.
Medication and administration methods
Methadone and buprenorhin are currently approved for this type of treatment. Methadone must be
drunk as a solution, normally in dosages from 80 to 130 mg/day. Buprenorphin is taken in the form
of high-dose resoriblets (Subutex) for putting under the tongue, normally in dosages of 8-16
mg/day. Considerably higher dosages are used when required.
In both cases the medication  must be taken daily under supervision until the patient is deemed to
be stable and to have sufficient mastery of his/her drug problem. Permission for take-home use can
then be granted to an increasing degree. Medication can be collected for maximum one week at
the time. The right to home-use is conditional on documented drug checks in the form of super-
vised urine samples. 
Suboxone containing buprenorphin and the antagonist naloxon are available on a registration-
exemption basis, but are so far not extensively used. It is expected that this drug will lead to less
need for control, since it cannot be taken intravenously. This reduces the danger of overdosing and
the tendency to resell will be less of a problem.
Psychosocial assistance interventions
Such interventions are conditional on individual action plans being drawn up which describe tar-
geted measures for dealing with the problems present. Every client must have a social consultant
who maintains regular contact and acts as coordinator. Inter-disciplinary responsibility groups must
be established for all patients with multiple problems, the social consultant and the regular GP shar-
ing principal responsibility with the specialised centre. All clients’ rehabilitation needs will be evalu-
ated and they will be offered education and training on this basis. Consultations with a psycholo-
gist will be provided if required
In practice, there may not be sufficient local competence or interest for this work. The specialised
facilities also have varying capacity in relation to the demand, which has generally been very high.
There have been some complaints that the treatment programme has to a large extent consisted of
handing out medication, control measures and conversations about the use of drugs.
Leakage
The system aims at a high degree of control, and the main rule is therefore daily administration of
medication under supervision. Close follow-up including regular supervised urine samples is a con-
dition for being given medication. Generally this works well when the regional facilities are in charge
of follow up and, if applicable, handing out medication. Nevertheless, methadone and Subutex have
been registered on the illegal market and in samples taken in connection with suspicious driving and
overdoses in persons who are not registered for treatment. Some of these finds can possibly be
attributed to illegal importation, but a substantial proportion must come from MAR medication. The
impression is that the problem is increased by decentralisation, with reduced regional control by spe-
cialists.
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Evaluation and statistics
All clients are registered as patients in a regional facility, even if their medication is prescribed by
their GP. The centres submit four-monthly reports to the national centre in Oslo on the number on
waiting lists, the number of admissions and the number of discharges. Figures are therefore avail-
able three times a year. There has been a steep rise in the number of clients. The latest figures from
August 2003 show an aggregate figure of 2,285 for the country as a whole (table 9). 2,995 per-
sons have undergone treatment at some stage or another. The most recent records show that 585
persons were waiting for treatment or for their applications to be considered. 
Table 9. Number of clients in medically assisted rehabilitation
Evaluation of the treatment has started, on the basis of ordinary reporting and research projects.
Very little has been published, however. A more systematic evaluation has started in the form of indi-
vidual reports on each patient from the patient’s main therapist. This “status report” describes the
client’s social situation at the time of reporting and the treatment administered (medication and psy-
chosocial). The report also includes clinically observed drug use and the results of urine samples for
the last month, the number of months the client is adjudged to have been drug-free, criminality,
and suicide and overdose figures for the last year. The preliminary reports from the autumn of 2002
indicate no proven or stated use of opiates among 60-90% of the clients during the last month.
It is too early to conclude on the effect of the treatment. So far, the information and studies indi-
cate a significant reduction in overdose mortality. The patients are more able to cooperate on the
treatment of other diseases. Most individuals experience a clear improvement in their social func-
tioning and quality of life. Criminality is substantially reduced. Many still have problems with the
continued use of drugs, especially benzodiazepines, and partly alcohol and cannabis. Trial projects
have also been carried out with buprenorphin. A randomised study was carried out of 106 opiate
addicts who were waiting to be admitted to the methadone programme in Oslo. Fifty-five received
buprenorphin – 51 received a placebo over a 12-week period. The conclusion was that the waiting
list patients benefited considerably from buprenorphin as a temporary treatment with respect to
relapse, self-reported use of narcotics and well-being. Nonetheless, the patients found it difficult to
remain in treatment over time without some form of psychological support (Krook et al: Addiction
2001).
A research project with buprenorphin for young opiate addicts was initiated in March 2002, led by
the Unit for Addiction Medicine at the University of Oslo in co-operation with psychiatric youth
teams in five counties. Seventy-eight persons have been admitted to the project, which aims to eval-
uate whether or not the treatment can lead to freedom from opiates. The project will also evaluate
the use of naltrexon to prevent relapses after completion of medically assisted treatment. Another
project will examine the use of methadone in patients with psychoses and opioid dependence, while
yet another project will examine the use of naltrexon implantates for those wishing a relapse pro-
phylaxis following abstinence-oriented treatment.
Training
All the centres conduct extensive training of personnel in cooperating municipal health and social
services centres. The Unit for Addiction Medicine has initiated courses for doctors in addiction med-
icine and maintenance treatment. Courses have been held in all the regions. This treatment has also
been incorporated into the curriculum for further training of social workers at several university col
leges (Helge Waal, UIO). 
No. of clients at No. of clients at No. of clients at No. of clients at
31.12.1998  31.12.2001 31.12.2002  31.08.2003  
173 1,501  1,984 2,285  
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11.4 After-care and re-integration
After-care and re-integration is a municipal responsibility described in the Social Services Act. After-
care is otherwise the weakest link in the treatment chain. Follow-up of and the building of a net-
work around individual clients is often poorly organised and can have a time horizon that is far too
short to be able to counteract a relapse into renewed abuse and the drug milieus. Experience shows
that life after completing treatment involves a unique set of problems requiring a different profes-
sional approach than that taken by other support services. Currently, there are too few support serv-
ices using this as their starting point. 
Several institutions run their own systematic after-care schemes and provide after-care housing. One
example is Stensløkka resource centre in Oslo. The institution admits clients of both genders and
couples, primarily those who have completed treatment for their drug problems. The overall goal is
to enable the users to make use of their intact and potential resources so that they, on completion
of their stay, are capable of coping independently – without drug abuse – finding housing,
work/education and a social network. 
The Idea Workshop is a unit of the Stensløkka Resource Centre. The facility is offered to former drug
addicts. The idea workshop is based on a learning facilitation approach and is a social meeting place
for people with a common background. It is an integration measure based on the participants'
resources and leisure interests. The overriding goal of all the activities included in the measure is to
contribute to the integration of the individual into "normal everyday life".
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Chapter 12. Interventions in the criminal justice system 
Regulations, laws and the correctional services’ legal practice were described in chapter  2.2.
12.1 Assistance to drug users in prison 
The control measures described in chapter 2.2 also have an important preventive effect in addition
to their control aspect. More specifically, for several years the Correctional Service has offered sen-
tencing alternatives that target the inmates’ drug problems and drug-related crime. During and after
serving a prison sentence, inmates with a drug dependence problem are offered participation in a
number of programmes. Such programmes include:
• Contract sentences, alternative to serving sentences in prison pursuant to 
the Penal Code section 12
• Drug-related influence programmes
• Life mastery programmes
• Establishment of networks
• Probation groups
• Work experience within the prison
• Education
• Leisure activities
• Participation in the prison system's work-furlough programme and 
support programme after release. 
A majority of the Correctional Service’s measures are concerned with issues that directly or indirect-
ly address the convicted person’s drug dependence. Over the last two years, Canadian drug mastery
programmes, called "Drug Prevention Programmes in Prison" (RIF), have been organised in some
prisons.  After release from prison these programmes will be followed up by the "My Choice" pro-
gramme, which aims to reduce the likelihood of relapsing.
Contract sentences aim to combat drug use among inmates. They are based on a contract between
the inmate and the prison, whereby he/she agrees to refrain from drug use while serving his/her sen-
tence. The contracts are entered into on an individual basis in ordinary prisons or in conjunction with
being transferred to a contract wing or contract prison. Normally no other demands are made of
the inmate with respect to participation in other rehabilitation measures apart from the requirement
that he/she must abstain from using drugs. Contracts are also used in non-custodial schemes, which
may include conditions and requirements concerning abstention from drug and alcohol use, drug
checks, frequency of attendance, participation in educational programmes, training in everyday
lifeskills, participation in discussion groups and efforts to plan for the future.
The HIV/AIDS issue involves major challenges for the prison system. An important aim is to protect
inmates and staff from HIV infection. There are intravenous drug users in prisons, and despite con-
trol measures, needles are sometimes used. In order to prevent the spread of disease through nee-
dle sharing among inmates, the Correctional Service, together with the Norwegian Health
Inspectorate, has reviewed the scheme whereby chlorine is available for cleaning needles. There are
no needle distribution programmes in Norwegian prisons.
Substitution treatment is provided to inmates who have already begun such treatment, so that they
can continue the treatment while serving their sentence. In principle, substitution treatment may
also be commenced while a sentence is being served, provided that the inmate satisfies the admis-
sion criteria for the programme (Ministry of Justice). The registered number of inmates receiving
substitution treatment has increased manifold and will continue to rise in the years to come.
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12.2 Alternatives to prison
The Execution of Sentences Act section 12 offers inmates with drug problems the opportunity of
being transferred to a halfway house or other treatment institution. Emphasis is on the institution
being able to offer a programme that meets the individual's needs. The law specifically requires that
there must be compelling grounds for a convicted person to serve his/her entire sentence in an insti-
tution, i.e. the convicted person’s need for treatment must be so great that the entire sentence
should be served in a treatment institution. In practice, this provision is used almost exclusively as an
alternative to prison for drug users.
The prison system does not have specific lists or approval schemes for relevant section 12 institu-
tions, but considers in each case whether an institution can offer a programme that suits the needs
of the individual in question. An institution will only be able to admit a convicted person in need of
treatment if his/her sentence can be served under secure conditions, so that the requirements for
alternative service of sentence are met. Facilities that only offer care are generally not accepted as
treatment institutions. Transfers can only be made to institutions in Norway. A total prohibition
against the use of alcohol and other drugs will be imposed on the convicted person for the dura-
tion of his/her sentence. This prohibition is also applicable during periods of leave, recreational activ-
ities, etc. As a rule, the opportunity to serve a sentence in a treatment facility/ halfway house is not
granted if the time remaining until expected release exceeds 12 months.
The Pathfinder Project is a rehabilitation programme run in co-operation between the Oslo prison
authority and the Tyrili Foundation, a rehabilitation facility. This alternative targets heavy drug users
and currently has capacity for 18 clients annually. Participants undergo an 8-month introductory and
motivating phase in the "Pathfinder house" at Oslo Prison, after which they are transferred to serve
their sentences under section 12 of the Execution of Sentences Act in the Tyrili Foundation's con-
tinuation treatment programme, which includes life and work training.
Influence programmes aim at crime prevention. They are based on dealing with social and person-
al problems assumed to contribute to crime. Violence and vice groups and release groups are exam-
ples of influence programmes.
The Drunk Driver Programme extends over one year and is an alternative to a custodial sentence. 
The Correctional Service cooperates with a number of organisations with humanitarian, religious,
sporting, cultural or drug prevention goals. These make a major contribution through home visits
and activity programmes that promote skills, improve self-esteem and integrate former criminals
into active recreational milieus. The intention is to strengthen such cooperation, among other things
by involving voluntary organisations more directly in planning while inmates are serving their sen-
tences. Special emphasis will be put on network building and on establishing inmates in positive,
drug-free milieus, already before their release (Ministry of Justice).
12.3 Further training
The Correctional Service, through its training centre, the Correctional Service of Norway Staff
Academy (KRUS) initiates and organises training for personnel who work with drug-related treat-
ment and control measures.
In 2003 KRUS has implemented the web-based refresher course “Narko på nett” (“Drugs online”). 
It has also organised web-based training in Motivational Interviewing (MI) or change-focused advice,
developed for persons with dependence problems. MI is one of the basic tools and an important
method for use by contact officers and those involved in various influence programmes.
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For the last three years, training in drug programmes has been conducted by a Canadian instructor
and twelve officers are trained annually for the implementation of programmes in non-custodial
schemes or prisons. The Drunk Driver Programmes have gradually been extended to include the
whole country, and are offered to persons convicted for very high blood alcohol content in connec-
tion with driving or for repeated drunken driving offences (Ministry of Justice).
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Chapter 13.  Quality Assurance
At present there are no formal quality requirements for establishing programmes for drug users. 
New initiatives to raise the quality of preventive measures were discussed in chapters 9 a) and 9 d). 
The issue of quality and quality assurance of treatment programmes has been raised on several occa-
sions. The Ministry of Social Affairs’ circular 1-1/93 on the Social Services Act etc. mentions quality
requirements in several places. The circular is not very concrete, however, and the amended Act from
1998 states that “The King may issue regulations to further provide for quality requirements in treat-
ment and rehabilitation programmes”, but no such quality regulations have been issued. Pursuant
to the current regulations anyone is free, in principle, to establish such programmes, but their oper-
ation will depend on whether or not the public sector is willing to buy the services offered. 
Pursuant to the Social Services Act the County Governors are responsible for supervising institutions
providing care and treatment for drug users. The purpose of such supervision is to ensure compli-
ance with laws and regulations and that clients are offered proper treatment and care. Supervision
shall focus on all matters of importance to the clients’ wellbeing, welfare and legal rights. The super-
visory body must visit the institutions at least four times a year. At least two of these visits shall be
without prior notice. 
The client registration tool, Addiction Severity Index (ASI), is used in treatment planning and
research. The adapted European version (EuropASI) is, for instance, used as the main instrument in
SIRUS’ cost-benefit study (chapter 11.2). Various treatment groups in Norway now wish to use
EuropASI and the youth version, European Adolescent Assessment (EuropADAD), for more exten-
sive client registration, both in order to meet the requirement for more emphasis on individual treat-
ment plans and in order to establish a basis for treatment evaluation.
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PART IV: Selected issues
Chapter 14  Evaluation of Drugs National Strategies
By Dag Rekve, Senior advisor, Ministry of Social Affairs
14.1 Existence of evaluation
The previous Action plan for reducing the use of alcohol and drugs (1998-2000) focused primarily
on preventive efforts, but included a strengthening of municipal intervention programmes for users.
The implementation of the plan as such was not subject to any separate evaluation.
The Government’s Action plan against alcohol and drug problems for 2003-2005 (see chapter 1.1)
includes close monitoring of developments for both alcohol and drug problems. The plan aims at
developing a system for measuring the extent to which the main goals and sub-goals of the action
plan are realised. The purpose of the system is to determine whether the measures that are imple-
mented are in line with and help to realise defined goals and strategies, and to uncover problem
areas and any needs for improvement. This requires that the goals are made operational, that indi-
cators for goal attainment are developed and that the various measures in the area can be linked to
these indicators and goals. The Ministry of Social Affairs has chief responsibility for the development
of the follow-up system, but is expected to work in close collaboration with other ministries, sub-
ordinate agencies and other players in the field.  
The development of a system of this kind that is meaningful will be very demanding in terms of
resources. It requires not only a good overview of available instruments and measures in the area
and their effects, but also good development indicators at the overall level. Extensive data has been
available in both these areas, some of which is adequately quality assured and systemised, while
other data has been collected on a more random basis and remains unsystemised. Nevertheless,
there are deficiencies in certain areas as regards indicators, particularly relating to registration of
harm. 
These deficiencies have delayed the efforts to establish a follow-up system, first and foremost, per-
haps, because the development of a sufficiently stringent system has proved very demanding in
terms of resources. Few countries or agencies have developed this type of system, and those that
have, spend a lot of resources on it, for instance the USA’s Performance Measure System which is
managed by the ONCDP. 
14.2 Methodology of evaluation
For the reasons mentioned in 14.1 the Government intends to start by drawing up a more inter-
vention-oriented document, showing how the different measures included in the plan are to be fol-
lowed up and by whom. It is a twofold system. New (project-like) interventions will be followed up
through reporting pursuant to a fixed template, while current policy task will be followed up by
means of the ordinary (existing) reporting tools. 
A system is being prepared for continuing with the goal and intervention structure of the Action
plan. The Action plan defines a total of 124 measures. All of them are reflected in the follow-up sys-
tem. The initiation and implementation of the measures will depend on several different sectors and
administrative levels. Some of the measures are partially overlapping. Some are permanent, while
others are concrete and for a limited period only. 
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In order to improve the coordination of drugs and alcohol policy at ministerial level, an inter-depart-
mental working group has been established. Each of the ministries is responsible for following up
measures linked to its own sector. However, the system will be used by all the ministries in their fol-
low-up. The Ministry of Social Affairs is responsible for coordinating the follow-up. 
Part I of the follow-up system will consist of collecting and systemising all the measures and clarify-
ing the distribution of responsibility at ministerial level. Where responsibility is split between several
ministries, or where several ministries have part responsibility, this will be made clear. Part I describes
how the follow-up is planned, and what this means to those in charge of follow-up. The status of
follow-up work is also included here.  Part II is a template for following up new measures or limit-
ed projects. 
The Ministry of Social Affairs has delegated a great deal of the responsibility for following up the
Action plan to the Directorate of Health and Social Affairs.  This includes coordination in relation to
the regional competence centres for drugs and alcohol issues, the National Police Directorate, the
Norwegian Customs and Excise and the Learning Centre.  The Directorate of Health and Social
Affairs will fulfil its share of the responsibility for follow-up by means of the ordinary reporting tools
such as agency management meetings and annual reports. Additionally, the Directorate files reports
using a fixed template for new measures and limited projects for which it is responsible.
As regards measures expected to be implemented at the municipal level, it is considered expedient
for the Ministry of Social Affairs to request the County Governors to collect status information.
Follow-up of the municipalities is intended to ensure that locally implemented  measures help to
realise the strategic goals of the Action plan. Here, it is necessary to develop a set of indicators that
adequately measure municipal activities in light of the Action plan’s objectives. 
As part of the Action plan the Directorate of Health and Social Affairs has been assigned the task
of coordinating a pilot project for locally based prevention over three years in selected municipali-
ties.  The model consists of a number of prevention strategies which are adapted to local needs and
implemented concurrently.  New measures that are implemented shall be based on research and
have a documented effect.  This pilot project will be evaluated by SIRUS.
In the long term the aim is to develop a system capable of measuring the effect of the measures
that are implemented in relation to the goals of the Action plan. The results of the follow-up will be
incorporated into the annual statement by the Minister of Social Affairs on the alcohol and drug sit-
uation in Norway, starting in the spring of 2004.
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Chapter 15.  Cannabis problems in context: understanding 
increased treatment demand.
By Martin Blindheim, editor of the journal ’rus & avhengighet’ 
(”alcohol/drugs and dependency”).
15.1 Cannabis use in the general population
Cannabis has been a part of all illegal use of drugs in Norway since the 1960s. Since then, after
alcohol, cannabis has been the drug with most users. Police’s statistics show that there have been
cannabis seizures throughout the country in recent years. 
Norway has several good data sets that show how the use of cannabis has evolved among young
people. The most important is the annual questionnaire survey conducted by SIRUS. For a more
detailed presentation and discussion of the data, see chapter 2.2.2. In recent years almost 30% of
young people in the 15-20 age group in Oslo state that they have tried cannabis at some time. At
the national level the figure is just over 15%. These figures are generally confirmed by several other
surveys10.
There is less reliable data on use by older age groups. A questionnaire survey on drugs and alcohol
habits in a nationwide representative selection of people aged 15–64 was carried out in 1991 and
1999 (chapter 2.2.1). The percentage that had ever tried cannabis increased from 9.6 to 15.4%11
In an opinion poll conducted for one of the newspapers in Oslo in 200312 around one third of the
respondents in the 30–39 age group stated that they had tried hashish. 
15.2 Demand for treatment for cannabis use
a) Client registration data 
A system for the registration of client data from out-patient and in-patient treatment institutions in
Norway is being developed (see chapter 3.1). The data is so far incomplete. Data is not supplied by
all institutions. Moreover, complete data sets are not collected for all clients. An important limitation
in the data is that there is no registration of the type of drug problems for which the clients are
admitted, only of the extent of their use of the different drugs. 
Data collected in 2001 show that 6% of the women and 9% of the men admitted to drug treat-
ment programmes in Norway stated that cannabis had been the most frequently used drug in the
six months before starting treatment (figures 12 and 13). The share has increased slightly for men
in the period from 1998 to 2001, while it has remained stable for women. A few large institutions
offering both in-patient and out-patient treatment have registered roughly the same proportions.
We emphasise that these are aggregate data. Several requests and registered courses of treatment
may therefore be attributable to one and the same client. 
10 The drug situation in Norway 2002. SIRUS 2003.
11 The drug situation in Norway 2002. SIRUS 2003.
12 Dagsavisen 6.10  2003
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Figure 12. Most Frequently used drug 1998-2001 women
Source:  The Bergen Clinics Foundation
Figure 13. Most Frequently used drug 1998-2001 men
Source:  The Bergen Clinics Foundation
Despite the limitations in the data, it can be assumed that only a small minority of the clients admit-
ted to Norwegian treatment programmes have drug problems that can be primarily ascribed to the
use of cannabis. 
b) A questionnaire survey
In 2003, in an attempt to register the scope of specific cannabis problems encountered by the treat-
ment services I sent a short questionnaire to 27 facilities containing questions relating to their expe-
rience of persons who needed treatment for problems with the use of cannabis13. The facilities reg-
istered in SIRUS’ database (www.rustiltak.no) was used as the basis. It includes out-patient services,
in-patient treatment and housing and care facilities. Seventeen facilities that can be regarded as
more or less representative, responded. I also contacted the outreach services in the cities and large
towns. This survey is an attempt to obtain a rough indication of how extensively treatment is
requested by cannabis users and to register the views of employees in the treatment services on this
matter.
Both the out-patient facilities and outreach activities, which work mainly with users under the age
of 30, state that they have clients who need help relating to their cannabis use. This applies to both
men and women. A minority of these clients only use cannabis substances, however; cannabis is
used in addition to a number of other drugs. The most common are alcohol, amphetamines, ecsta-
sy and tranquilizers. A typical comment from a psychiatric youth team: ”The users present their
other problems first; their use of ”hash” is often disclosed after some time.” 
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In-patient institutions have the impression that the use of cannabis by clients is stable or slightly on
the increase. Employees feel that many people have problems relating to the use of cannabis, but
that such use nearly always takes place in combination with other drugs. One big treatment foun-
dations states, for example: ”Nobody says that they have only used cannabis”. Another states: ”We
have multiple drug abusers. They all start by using cannabis – then they extend their abuse.” 
c)  Substitution treatment
In medically assisted rehabilitation, cannabis together with tranquilizers is often part of  ”addition-
al abuse” of other drugs. The policy for dealing with this varies, but such use of drugs is incompat-
ible with participation in medically assisted rehabilitation. This has proved difficult to enforce, how-
ever. Many of the facilities state that they ”therefore turn a blind eye to” (modest) use of other
drugs and choose to focus on bettering the quality of life rather than on the client being drug-free.
d) Relapse
A large proportion of those who have undergone treatment, will after a shorter or longer period
relapse into a situation in which their lives are marked by the use of drugs. Many relate how the
relapse has been a process in which the drug user started with a moderate intake of alcohol and/or
hashish and gradually lost control. Many after-care measures, therefore, systematically target the use
of alcohol and cannabis in an apparently normalised life style. The users are always recommended
to stay completely away from cannabis substances.
e) Sources of referral
The services come into contact with their clients by way of referrals from a broad range of agencies:
the primary healthcare services, schools, social services, psychiatric services, the correctional service,
parents and through user requests. We have no information as to whether those with specific
cannabis problems are mostly referred by particular agencies. 
f) Reasons for treatment demand
We have insufficient information to properly answer this question.
g) Profile of clients
The limitations of the registered client data make it difficult to provide a more detailed description
of the minority admitted to treatment primarily due to cannabis problems. 
The questionnaire (15.1.b) included two questions relating to client characteristics. The respondents
replied that the youngest among those who used cannabis extensively have problems associated
with “dropping out” of family, school and social contexts, while the older users have mental prob-
lems such as anxiety/ depressions and general antisocial behaviour. One of the facilities replied that
“being high becomes a way of life, with personal, family and social problems as a consequence.”
The existing data do not allow for a more comprehensive description of clients who use cannabis
frequently. 
h) Changes in legislation
There have been no changes in the legislation affecting cannabis or other illegal narcotic substances.
All use, possession, procurement, production and sale of cannabis is still a criminal offence under
the Penal Code and/or the Medicinal Products Act. Law enforcement is less strict today, however,
than it was only a few years ago. Today’s sanctions are milder for possession/ import for own use
than if the intent is sale/ profit. In practice small quantities of cannabis for own use are no longer
subject to criminal proceedings. 
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15.3 Prevalence of problematic cannabis use and patterns of problems
a ) Prevalence of heavy use
Norway has no existing generally accepted definition of ”problematic cannabis use”. Vague defini-
tions linked to behaviour and to the part the drug “plays in the life of the user” have been sug-
gested, but are not commonly used. “Habitual use” is a term often used, but which has not been
clearly defined. In connection with SIRUS’ questionnaire surveys, ”regular use” was defined as more
frequently than ten times in the course of the last six months. This type of definition says nothing
about the extent of the problem, however. 
As regards Norway there are only grounds for saying something about the frequency of use. In the
SIRUS surveys (young people aged 15–20) 7–10% nationwide and approx. 15% in Oslo stated that
they had used cannabis during the last 6 months14while 3–4% stated that they had used it during
the past month. Around 3% at the national level and around 7% in Oslo stated that they had used
cannabis ten times or more in the last six months. 
SIRUS points out that ”there is reason to believe that young people who regularly use narcotic sub-
stances, be it cannabis or stronger substances, will be underrepresented in the surveys”15. There are
therefore grounds for suspecting that the actual percentages are higher.
We have no surveys that provide any data about habitual use of cannabis in the adult population.
Nevertheless, researchers have agreed on several occasions that the use of cannabis in Norway is
mainly a youth phenomena.
b) Cannabis and driving accidents16
Norway has no available statistics on the number of traffic accidents involving drivers who have used
cannabis substances. The National Institute of Public Health’s department of forensic toxicology,
which analyses blood samples for the police among others, has reported that in a 15-month period
they registered a sixfold increase in the number of blood samples from drivers stopped by the police
on suspicion of being under the influence of other drugs than alcohol. After alcohol, cannabis is the
substance most frequently detected in such analyses. The number of samples testing positive for
cannabis increased from 564 in 1990 to 1,886 in 2002 (chapter 3.4.1).
c) Social problems related to cannabis
In Norway there has been no research that demonstrates a causal relationship between the use of
cannabis and social problems. Several studies demonstrate that there is a relationship, however, and
possible explanations are discussed.
The Young in Norway survey (Norwegian Social Research - NOVA), which analysed various aspects
of young people’s life situation, including drugs and alcohol use, showed that extensive use of
cannabis is linked to a high consumption of other drugs, criminal behaviour and problems at school
and in the workplace17. 
SIRUS’ questionnaire survey18 shows more extensive use of cannabis among those living with only
one or neither of their parents than among those living with both their parents. There is also a clear
relationship between interrupted education and the use of cannabis at least once, and also between
a feeling of satisfaction with one’s own life and the use of cannabis. 
14 Skretting, Astrid. Ungdom og rusmidler. The Directorate for the Prevention of Alcohol and Drug Problems,
Oslo 2000.
15 The Drug Situation in Norway 2002. SIRUS 2003.
16 Data from: Drug problems in Norway 2000. Ministry of Social Affairs 2000.
17 Pedersen, Willy: BitterSøtt, Universitetsforlaget, 1998.
18 Skretting, Astrid. Ungdom og rusmidler. The Directorate for the Prevention of Alcohol and Drug Problems,
Oslo 2000.
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d) Psychiatric problems related to cannabis use
In Norway no figures are available as regards cannabis-triggered psychoses or other mental health
problems.  The discussion on whether or not there is a relationship between the use of cannabis and
the development of mental illnesses crops up at irregular intervals. The term cannabis psychoses has
been launched in this context. In Norway, as in other countries, the professionals seem to agree that
there is a correlation between mental problems and the use of cannabis, but opinions differ about
possible causal relationships. 
e) Health problems related to cannabis
No surveys are available in Norway that document specific health problems relating to the use of
cannabis. 
15.4 Specific interventions for problematic cannabis use 
Among those who replied to the questionnaire (15.1.b), only three stated that they had tried out
interventions for cannabis users. Very few respondents answered that they knew of others who had
implemented such specific interventions. The lack of specific interventions for cannabis users is 
confirmed by searches on the internet, where the hits almost exclusively concern medical use of
cannabis. 
Of particular interest, therefore, is a recently started cessation programme for cannabis users organ-
ised by the outreach service in Stavanger. This is described in more detail under a). 
Of the two other facilities that replied that they had experience of own measures, one psychiatric
youth team reported that it had organised discussion groups for ”cannabis quitters” a few years
ago. This measure was not described in detail, but reported to be ”successful”. 
To the question of whether there is a need for treatment of cannabis problems, most facilities reply
that they see an increasing need, but without stating any exact figures or supporting their state-
ments in any way. Opinions differ as to whether the need should be met by specially developed
measures or whether it can be met by existing measures. Those who believe that new measures are
required have proposed individual treatment and discussion groups using cognitive therapy, and
group therapy using the same model as courses to wean smokers off nicotine.
a) Smoking cessation for cannabis users
In spring 2003, the outreach service in Stavanger carried out a pilot project aimed at young people
who wished to stop using cannabis. The project has been thoroughly described.19
The starting point for the project “Stop smoking course for hash smokers” was the statistic showing
that a quarter of this group uses so much that it “will influence their lives in a negative direction.” 
Those in charge of the project say that “it proved difficult to find anyone at all in Norway with expe-
rience of group therapy in relation to cannabis. They therefore chose to develop a course based on
Swedish material that was translated into Norwegian20. 
The target group for the course was “Young people who have expressed a desire to stop smoking
hashish and who believed that they needed help to do so.” The goal of the course was to become
drug-free “with a view to freeing the young people’s resources so that they would be able use their
talents and abilities.”
19 Hege Sundby and Zoila Santiago: Røykeavvenningskurs for hasjrøykere. Project report . Outreach service in
Stavanger 2003. All quotes in this chapter are taken from a preliminary draft of the project report and are
reproduced with the authors’ consent.
20 Thomas Lundqvist: En guide for deg som vil slutte med hasj. The Borgestad Clinic competence centre, 1999.
N A T I O N A L  R E P O R T  2 0 0 3  –  S I R U S
70
The methods employed consisted of discussion groups that focused on problems experienced by the
participants themselves and the development of mastery strategies in relation to them. The discus-
sions were combined with ear acupuncture using the NADA method, relaxation exercises and other
means of fostering “wellbeing”.
The course started with five participants and lasted for six weeks, with thrice-weekly meetings dur-
ing the first weeks gradually decreasing to one meeting per week. Three of the participants com-
pleted the whole course, and all five participants have stated that they have reduced their cannabis
use greatly or stopped completely. Those in charge of the project say that the participants them-
selves point out “that the success of the course is in large part due to them being part of a group”
with discussions in which they could exchange experiences, receive support and backup with respect
to how hard it was.
All the participants expressed great satisfaction with the wellbeing part of the course. All the par-
ticipants will be contacted as part of a six-month evaluation “to register their general life situation
and degree of freedom from drugs.” 
The outreach service’s summing up is that the project has been so successful that it intends to start
a new course in October 2003 following the same model. The most important change will be to
extend the course to eight weeks. Several other outreach services, in Bergen and Oslo among oth-
ers, wish to copy this course.
b) Schools 
Traditionally, schools in Norway have been an important arena for prevention of drugs and alcohol
abuse and associated problems. For years, cannabis has been seen as a “gateway drug” to heavier
use of illicit substances and schools have focused strongly on cannabis. Endeavours have been
made, however, through the school counselling services to offer help to students who are in the
process of developing problem behaviour rather than expel them. This work has not been system-
atically summarised, but our impression is that endeavours are made to view the students’ life situ-
ation as a whole rather than focusing exclusively on the use of specific drugs.
c) Workplaces 
Through the work of the Tripartite Committee for the Prevention of Alcohol and Drug Problems in
the Workplace (AKAN), Norway has a unique and recognised system for prevention and for provid-
ing assistance to employees who are in the process of developing problems relating to alcohol and
drugs. As in schools, attempts are made to help and integrate employees with alcohol and drug
problems instead of firing them, and focus is placed on their total life situation rather than on their
abuse of drugs or alcohol. There are no good data showing the prevalence of alcohol and drug
problems in Norwegian workplaces. Nor is the work of the Tripartite Committee for the Prevention
of Alcohol and Drug Problems in the Workplace (AKAN) linked to specific intoxicants. 
15.5 Conclusions
• Between a fifth and a quarter of young Norwegians aged 15-20 try cannabis substances at 
least once. 
• A smaller proportion of this age group (15-20) uses cannabis frequently, while only a small 
group develop habitual use.
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• For persons with an extensive consumption of illicit drugs, cannabis often constitutes an 
important element in their abuse. 
• Very few of those who avail themselves of facilities in the drugs field, have problems 
exclusively linked to the use of cannabis substances.
• Experience of special interventions aimed at those with cannabis-related problems 
is highly limited. 
• Several facilities have expressed the opinion that such measures are required.
Problem use of cannabis is overwhelmingly perceived as being part of a broader substance abuse
problem which involves several substances. It is to some extent also perceived as being an expres-
sion of underlying mental problems. It is difficult to say whether this is an expression of the situa-
tion as it actually is or whether cannabis-related problems have been “overshadowed” by graver
problems relating to harder drugs, and have therefore not been recognised and addressed through
relevant interventions.
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Chapter 16. Comorbidity
By
Tone Øiern, journalist for the professional journal ”rus & avhengighet”(alcohol/drugs and
dependency);  
Reidun Evjen, head of department of the Tøyen branch of Medically Assisted Rehabilitation
in Oslo; 
Knut Boe Kielland, general practitioner, supervising physician at the State clinic for drug
addicts and advisor to the Eastern Norway competence centre.
Comorbidity between intoxication and psychiatry has many different aspects. It may involve clients
with serious mental problems such as schizophrenia or a bipolar disorder, where the concept of dual
diagnosis is often used. Clients with very serious personality disorders also belong in this category.
Comorbidity in this context may also include a number of alcohol/drug-abusing clients displaying a
wide range of slightly less serious mental problems, anxiety and depression being their main symp-
toms. They may be marked by having grown up under difficult conditions, and some may also be
marked by traumatic experiences in childhood and adolescence. Social abjectness and difficulties in
utilising existing treatment facilities are often central characteristics. In the following description, we
will take a relatively broad approach to various mental health problems in alcohol and drug abusers.
The treatment statistics (Skutle & Iversen 2002, Iversen 2002) show that 26,000 courses of treat-
ments for abuse of legal and illicit substances were carried out in Norway in 2000. In the Norwegian
medication-free treatment the same methods are often employed regardless of which intoxicants
the patient/ client has used. There are various treatments available to young people and adults, and
there are a few treatments available only to women or only to men. The treatment statistics say
nothing about the clients’ mental health problems or illnesses. 
A cross-sectional survey is carried out every five years in the mental healthcare sector on patients
admitted to psychiatric wards. In 1994 the survey included 3,060 patients21 Approx.16% of these
had a serious drug abuse problem (Norwegian Board of Health 2000). However, it is known from
other surveys that registration of alcohol and drug abuse is often inadequate, so that it is reason-
able to assume that a higher proportion of the psychiatric patients had substance abuse as an 
additional problem. 
16.1 Main diagnoses, prevalence
In recent years a number of surveys have been carried on Norwegian abuser populations in order to
study mental infirmity. These studies have involved alcohol or drug users who are undergoing some
kind of treatment or other. The most thorough was the Alcohol/drug use and psychiatry survey (ROP)
carried out by the Eastern Norway competence centre in 1997-98. Two hundred and sixty clients
who were either in out-patient treatment or in institutions for alcohol and drug problems were stud-
ied. Of these
• 91% had lifetime experience of suffering from psychiatric complaints
• 83% had suffered from anxiety
• 44% had suffered from depression.
21 In a corresponding cross-sectional survey from 1999, questions directly relating to alcohol and drug abuse
were not asked. 
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Only one single patient in this population had symptoms commensurate with schizophrenia, while
14% had schizotype personality disorders. In all, 72% had personality disorders, of which evasive
and passive-aggressive were the most common. Thirty-one per cent had antisocial personality dis-
orders, while 44% met the criteria for more than two personality disorders (Landheim et al 2000).
The study also showed that a high proportion of the women (38%) satisfied the criteria for post-
traumatic stress disorder (PTSD). The same applied to 17% of the men. For most of the clients the
psychiatric symptoms appeared to predate the alcohol or drug abuse (Bakken et al 2002). The sur-
vey shows a lower degree of social integration in family and working life than several other
European and North American surveys of corresponding populations, which indicates that this is a
very abject group of substance abusers. 
Both the ROP survey and other surveys in Norway show that a high proportion of drug users have
had pretty massive family problems, during their upbringing and in school. A survey of 2,359 drug
users undergoing treatment in 1992-93 showed that 70% had experienced learning and behav-
ioural problems in schools, 38% had experienced bullying and 21% had received psychiatric treat-
ment during childhood or adolescence (Lauritzen et al 1997). The survey was based on questions
put to therapists, who stated that 57% of the clients currently had problems with depression and
56% with anxiety. Forty-three per cent had experienced life-threatening overdoses, and 33% had
attempted suicide. The survey did not provide good information concerning personality disorders
and psychoses.
A survey carried out at a therapeutic community for alcohol and drug abusers in Oslo also found a
high proportion (69%) with depression, measured using self-reporting methods (SCL 90 and
MCMI). Those who were still depressed on discharge had a considerably higher drop-out rate dur-
ing the after-care phase than the other clients. These were assumed to be individuals with more pro-
nounced depression who would probably benefit from a more specific antidepressant psychothera-
peutic and medicinal treatment. The survey also demonstrated that clients with antisocial character
traits coped better during the 12-month stay in the institution than more withdrawn, cautious and
anxious clients. However, clients with pronounced antisocial traits often dropped out during the
after-care phase. (Ravndal & Vaglum 1994).
In 1999, the Norwegian Board of Health carried out a registration of the prevalence of patients with
dual diagnoses in Norway and their treatment needs. The registration was based on clients known
to have such problems, in the psychiatric sector, the alcohol and drugs sector and in the municipal-
ities. The Norwegian Board of Health concluded that there were approx. 4,000 individuals in Norway
at that time (9 per 10,000 of the population) who had both a serious psychiatric complaint and an
extensive alcohol or drug abuse problem, and who needed treatment facilities over and above the
existing ones. Roughly half of them primarily had alcohol problems. Of the 4,000 individuals,
approx. 1,200 were thought to have schizophrenia-like psychoses or bipolar disorder, 800 had seri-
ous depression or anxiety or similar complaints with a very serious dysfunction, and approx. 1,700
had a serious personality disorder, most of which were of the emotional instability or dissocial type.
A group of more than 300 persons with serious cognitive dysfunction, either in the form of mental
disability or impairment of more selective cognitive skills, was also included.
The above-mentioned surveys concern alcohol or drug users undergoing some form of treatment.
Some reports are also available on clients not undergoing treatment. Naturally, these are less exact
and consist of evaluations of problem loads in clients in various types of low-threshold facilities.
Some were carried out at acute accommodation facilities for the homeless, others at low-threshold
heath facilities for drug users. What they have in common is that they show a significant load of
combined problems involving alcohol/drug abuse and psychiatric symptoms in these populations.
These problems include schizophrenia, personality disorders, mental effects of traumas such as rape
or other types of violence. They also include mental health complaints that are closely related to the
substance abuse itself (SINTEF Unimed 2003, Feltpleien 2001).
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16.2 The impact of comorbidity on services and staff
With the exception of a few ambulant measures, housing facilities and specialised treatment units
(chapter16.4), there are few examples of measures tailored to the needs of this type of comorbidi-
ty. These are patients in mental healthcare, particularly in acute facilities, out-patient alcohol/drug
or psychiatric services, in facilities provided by humanitarian charitable organisations (warm-up cen-
tres), low-threshold accommodation facilities (hostels) or in institutions run by the correctional serv-
ices.  Because of the compound nature of the problems involved, they are also in receipt of servic-
es from many different agencies, both welfare and care facilities and specialised treatment facilities
in the areas of alcohol/drug abuse and psychiatry. There is reason to assume that in Norway this
patient group experiences that it meets with a somewhat inconsistent response.  
It has been decided that services that address the needs of those with dual diagnoses will be inte-
grated in a comprehensive patient and intervention-based national plan that was instigated in 1999
and will run for eight years. Its goal is to expand both specialist and care services (Escalation plan
for mental health (1999-2006) in 2003, proposed extended until 2008). On the basis of the regis-
tration of the situation of dual diagnosis patients, the Ministry of Health has issued a guideline that
“this group needs special services with special expertise, both in the form of separate in-patient
facilities and out-patient follow-up.” Rather than establishing special projects, it will be most expe-
dient in Norway to integrate new services with already existing facilities. Three or four integrated
teams based on experience of ACT (Assertive Community Treatment), inspired by the New
Hampshire model among others, are now being tested in the mental healthcare sector in Norway.
In general, treatment evaluation shows that it is important that those who work with persons with
dual diagnoses simultaneously address both the alcohol/drug abuse problems and the mental illness.
More training is required in special attitudes and techniques adapted to clients with combined prob-
lems. Such programmes are in the process of being introduced in some places.
Increased competence can be achieved in many ways, for instance by establishing a common train-
ing programme that will be able to ensure mutual exchange of experience between different pro-
fessions. Systematic training of staff can also take place through practice periods in workplaces
which have the competence required.  There are currently a number of short courses available on
mental health problems and alcohol/drug abuse. However, there is no distinct speciality in the treat-
ment of dual diagnoses in Norway at present. Nor is the treatment of alcohol/drug abuse a medical
speciality. It is possible for those with university college qualifications to supplement their education
by taking a two-year course of further training in substance abuse treatment or mental healthcare
work. Both these educational courses include the treatment of mental health problems in combi-
nation with drug/alcohol dependency. Studies leading to a masters degree in mental health work
are also planned and comorbidity will be part of the course of study. Courses in medicine relating
to alcohol/drug abuse have also been initiated for doctors. 
Six of the seven regional competence centres are attached to clinical milieus and each centre has
specialised in one area relating to drugs and alcohol. The Eastern Norway competence centre has
“dual diagnosis” as its speciality field and it has carried out extensive registration of the mental
health of clients seeking treatment for alcohol or drug abuse in two counties (chapter 16.1). Various
forms of knowledge and competence building around alcohol/drug abuse and psychiatry is being
carried out in all five Norwegian health regions. 
16.3. Service provision for persons with drug abuse and 
psychiatric complaints
There are several reasons why persons with alcohol/drug abuse and psychiatric problems are diffi-
cult to reach with treatment. It is normal to attribute this to the patient’s situation, but the difficul-
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ties may also be due to poor interaction between the support services and the patient.  The fact that
the local community, the treatment services and society as a whole lack understanding of the client’s
assistance needs, for instance, may lead to such people being described as “lacking motivation”.
Persons with dual diagnoses may have many reasons for feeling despondent and without any hope
for the future. They have often had many negative encounters with the support services and may
therefore resist new treatment.  This may lead to them being blamed for a poor treatment result,
which might equally well be the result of the helplessness of the support systems. 
The ordinary health services, both somatic and psychiatric, have generally proved unable to reach
heavy substance abusers to a sufficient extent. This has led to the development during the last two
years of low-threshold health services in the cities and large towns. The aim is partly to provide
health services and partly to establish contact with the regular health services. Among other prob-
lems these patients have – and this is hardly peculiar to Norway – is the fact that they have poor
networks of family and friends as well as poor education and work experience. Their contact with
psychiatry is often characterised by brief admissions, often on a compulsory basis, but seldom for
systematic long-term treatment. There are frequent interruptions in therapeutic relationships instead
of continuity. 
A select committee appointed four years ago by the Ministry of Health and Social Affairs (Ministry
of Health and Social Affairs 1999) concluded that persons with dual diagnosis problems often
become clients of the alcohol and drugs services, even though the mental healthcare services would
in many cases have been able to provide more adequate treatment. This may have to do with the
fact that capacity considerations are often decisive with respect to where clients are offered treat-
ment, rather than which treatment options would best suit the client. 
Employees in three low-threshold facilities and two rehabilitation centres in Oslo were interviewed
about how persons with dual diagnoses for whom applications are submitted, are treated by the
institutions (Bjøntegaard 2000). With one exception all the five facilities accepted dual diagnosis
clients.  They regarded themselves as the system’s “losers” because there were great difficulties
attached to getting others in the support services to assume further responsibility for this group.
Funnelling the client from a low-threshold facility to treatment/rehabilitation was experienced as
being very difficult. They felt that they could not provide adequate help themselves because they
lacked competence, manning, time and other resources, because storing medicines and adminis-
tering medication was outside the institution’s responsibility and because they had to take other per-
sons in the facility’s target group into consideration. 
It was clearly the case previously that persons with dual diagnosis were often excluded from alco-
hol/drug abuse treatment because of their mental problems and from psychiatry because of their
alcohol/drug problems.  This still happens but there may be grounds for believing that the efforts
described here mean that it happens less often than before. Evaluations of individual patients, par-
ticularly of their mental health problems, are difficult to perform while the patient is intoxicated and
also during the first period after they stop their substance abuse. It is important to be able to repeat
the psychiatric evaluation during the course of treatment.
Several regions have initiated specific measures aimed at reaching individuals who are in the process
of developing schizophrenia as early as possible – since research indicates that early treatment can
improve the prognosis. These projects show that many of the patients in question also have serious
substance abuse problems. The projects have therefore emphasised integrating the treatment of
these two problem areas (chapter16.4). 
Another problem which is more pronounced in patients with comorbidity than in others, is the dif-
ficulty of obtaining and holding on to a place to live. There is a substantial need for supported hous-
ing for this group. How such houses can best be designed and manned is a matter still under dis-
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cussion. There are plans to allocate funds for this purpose in the escalation plan for psychiatry, but
whether the allocated funds will be adequate is uncertain. It is also uncertain whether the munici-
palities will place sufficient emphasis on the needs of the target group when distributing funds.
At least half of those serving prison sentences are assumed to have a drug-related history; they are
serving short or long sentences for violation of drug laws (30%) or for crimes closely related to their
drug abuse (20%). The treatment of psychiatric complaints during prison sentences has often
proven difficult. Nor do most inmates receive meaningful treatment for their drug abuse. No good
Norwegian study is available on mental health problems and drug use among inmates in Norwegian
prisons, but many of the clients in prisons are clearly not unlike those in treatment institutions for
drug abusers. The relapse rate is high among drug users who have served prison sentences, and
there is increasing recognition of the fact that prison terms can contribute to a worsening of men-
tal health problems and unfortunate patterns of behaviour. 
Norwegian legislative provisions relating to the treatment of those with alcohol and drug
dependency problems
The Mental Healthcare Act (section 3) authorises the use of compulsion in mental healthcare, in or
outside institutions. This possibility can also be used for seriously mentally ill alcohol or drug abusers.
This authority is most often used in very acute psychotic episodes, but it is possible to use it with-
out special time limitation in the most serious cases. In general, compulsion is more often used for
acute admissions to psychiatric institutions in Norway than in many other Western countries.
Compulsion is more often used for committing mentally ill alcohol and drug abusers than other psy-
chiatric patients (Norwegian Board of Health 2000a, annex 2). 
The Social Services Act (section 6.2) authorises the admission without consent of alcohol and drug
abusers for stays of up to three months in institutions. It is a precondition that the client’s abuse seri-
ously threatens his/her life or health. This section is relatively little used. The Mental Health Act is
most frequently used in connection with alcohol and drug abusers with mental illnesses (normally
psychosis). 
The Execution of Sentences Act (section 12) allows for treatment in an institution during the serv-
ing of a prison sentence (section 12.1). This possibility is used, but only in a very small proportion of
cases where alcohol and drug abusers are serving sentences. There is no reliable information as to
whether it is more often used for mentally ill drug users than other users. All inmates in Norwegian
prisons are offered medical examinations but it is uncertain whether this is sufficient to detect all
cases of serious mental illnesses. Reports are available from some prisons concerning the extent of
mental illness and drug abuse, but no systematic registration of this has been carried out. 
In Norway, there is a widespread understanding that drug users should serve their sentences in such
a way as to facilitate treatment and follow-up, but treatment is not instigated by the correctional
services. Only recently was a working committee appointed to evaluate the Penal Code’s authorisa-
tion of the use of compulsion in the treatment context, through the postponement or cancellation
of sentences if a person becomes drug-free. 
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Voluntary treatment
In the international context, Norway has one of the highest numbers of treatment places for alco-
hol and substance abusers and, traditionally, it has concentrated a lot of its resources on treating
addicts in institutions, compared with the resources used by the municipalities on long-term help in
clients’ local communities.
Evaluating patients in Norwegian alcohol and drugs facilities for further help in mental healthcare
necessitates cutting across administrative boundaries. Very many alcohol and drugs facilities report
difficulties in getting specialists in mental healthcare to take responsibility for meeting the treatment
needs of a patient group that requires specialist services from both sectors. The reform which entails
including both alcohol/drug treatment and mental healthcare under the same regional health trusts,
aims to improve cooperation between the specialist health services. Including these services under
the same administrative level will give the alcohol/drug treatment services the same status as spe-
cialist health services on a par with the specialist psychiatric service. This will facilitate coordination.
The specialist health services’ responsibility for the treatment of alcohol and drug abusers will be
strengthened, thus improving the services provided for this group. 
It is emphasised that an interdisciplinary approach is a precondition for achieving the goals in the
escalation plan for mental health. Competence in the social work field and a knowledge of network
building are seen as necessary requirements for helping clients to manage on their own in support-
ed housing and helping with supported employment. The municipalities are responsible for care
services, while specialist responsibility rests with the state. Because many of these persons need both
treatment and care, i.e. simultaneous help from both specialist services and the municipality, it is
very probable that clients will simply be passed form one service to the other. In order for the coop-
eration to work on the user’s terms, it is important that professional care work is given the same sta-
tus as other approaches. The number of out-patient, and a in a few cases in-patient, facilities treat-
ing patients with comorbidity is increasing. Developments have also taken place in alcohol/drug
treatment measures through the addition of psychiatric competence.
Specialised teams
There are 34 specialised teams for adolescents and young adults with drug dependency problems,
the Psychiatric Youth Teams (PUT). The teams include professionals such as doctors, psychiatrists,
social workers and child care workers and offer consultations on an out-patient basis.
In a survey the teams themselves estimated that 30% of their clients suffer from serious mental
problems in addition to substance abuse. Nearly one in three clients break off treatment and one in
three fail to attend treatment appointments. A publication about the needs of persons with dual
diagnosis today states that “Therapeutic services are of little value if you do not know where you
are going to sleep at night or how you are going to get your next meal” (Bratteteig, 2001). The
Ministry of Health and Social Affairs wants to give priority to persons with dual diagnosis and to
redirect resources from PUT to special measures for drug users with serious mental illnesses,
(Storting Report 25, 1996-97), and proposed the setting up of “special services for young people
with alcohol and drug problems and mental illnesses in each county. These could take the form of
one or more “Psychiatric youth teams” attached to the central hospitals’ departments for alcohol
and substance abuse-related psychiatry or to one or more district psychiatric centre in each county.
The teams should work externally and take an outreach approach. Any reorganisation of the serv-
ices should be carried out in such a way that existing competence is preserved.”
Three to four teams have been established to test models for ambulant/ outreach services aimed at
persons over the age of 18 with a dual diagnosis. They consist of inter-disciplinary units that togeth-
er have high competence in the comorbidity field and where one and the same group of therapists
will be able to deal with both alcohol and drug abuse and mental illness.  
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The department of alcohol/drugs-related psychiatry at the Psychiatric Clinic at Rogaland central hos-
pital has set up two ambulant groups22 each attached to a psychiatric youth team intended to reach
patients with abuse problems and mental illness and who do not avail themselves of, or drop out
of, existing services.  The team in Sandnes has had 44 patients up to October 2003, most of them
between the ages of 25 and 35. Twenty-four of the patients have psychosis problems. Thirty-one of
them do not have satisfactory housing arrangements. An evaluation of the project is planned.   
In Oslo the project  Alcohol/drug use and psychiatry (ROP) is attached to a district psychiatric cen-
tre.  The project, which started in January 2001, will run for five years and is staffed by psycholo-
gists, psychiatric nurses, social workers and psychiatrists.  The target group consists of patients from
Oslo who have difficulty, or are completely incapable of, availing themselves of the general health
and social services. They must have serious drug dependency problems of at least two years’ dura-
tion, and there must be grounds for assuming that they also suffer from serious mental health symp-
toms such as schizophrenia, schizotype disorders, bipolar disorder or serious personality disorders.
The project will offer follow-up for up to two years. The team will be very accessible. It will be pos-
sible to contact/visit the patients at home, in hostels, on the street or in prison. The focus will be on
basic needs such as housing, work, social benefits and social relations. The project will be evaluat-
ed through interviews with a selection of patients and collaborating partners, by systematising diag-
nostic material. 
Up to summer 2003, 64 patients had been helped by the project and 25 had completed treatment
and been discharged.  Sixty per cent have no fixed abode. Their average age is 34. Twenty-five of
them are opiate users, while most (50%) are multiple users. Twenty-one of the patients are receiv-
ing treatment using methadone or Subutex, and these patients appear to be benefiting more from
the project than those not receiving substitution treatment. It is estimated that 49% have psychot-
ic illnesses, 14% affective disorders and 25% personality disorders or other mental problems.
Among those with psychoses, many have more than one additional diagnoses. (Øverås 2003).  The
goal is to establish a parallel service to the existing one, but that contact with the regular help agen-
cies will be established and maintained during the period the patient is part of the project. The proj-
ect has generated cooperation on depot medication pursuant to decisions to use compulsion, where
the medical responsibility lies outside the team. 
In-patient treatment
There are 6-7 in-patient treatment facilities in the alcohol/drugs and psychiatry field that include per-
sons with dual diagnosis problems in their target group (Evjen 2003). The treatment facilities either
have expertise on dual diagnoses themselves or they bring in expertise for guidance purposes. So
far, there has been no research into or evaluation of these facilities. 
One survey of a hierarchic therapeutic community in Norway (Ravndal & Vaglum 1994) showed that
patients with antisocial personality traits coped fairly well during the actual stay in the institution,
but that they had a high drop-out rate in the after-care phase. It was concluded that the situation
following discharge should probably include structural elements and limits similar to those applying
during the stay in the institution.
Medically assisted treatment 
Treatment of opiate addicts using methadone was initiated in Norway in 1998. A three-year trial
project, the Methadone Project in Oslo (MIO), tried out in advance a model that included close fol-
low-up, control and active rehabilitation in addition to medical treatment. The evaluation showed
that anxiety and depression were widespread among the patients. These problems improved only
slightly during the project period. The evaluation concluded that treatment specifically aimed at the
22 Cf. The Ministry and Health and Social Affairs’ circular 1 – 36/2001.
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mental health problems is essential. It was also the case that those with antisocial personality disor-
ders completed the programme as successfully as those without such problems. This reinforces the
supposition that for clients with such personality disorders, stringent rules, control and predictabili-
ty - as found in the Norwegian model - have a positive effect.
A research project on the use of substitution treatment for patients with schizophrenia and opiate
abuse is in the start-up phase. The project will be carried out by the Section for clinical drug prob-
lems at the University of Oslo and will initially include 40 patients with medium to serious opiate
abuse and schizophrenia.  The aim is to test the use of substitution treatment, which will be admin-
istered by a hospital department in the initial phase and subsequently by the district psychiatric cen-
tres. Among other things, the study will evaluate how well psychiatric treatment works for these
patients. Extensive diagnostic examinations will be performed prior to inclusion and after two to
three years. A questionnaire survey will also be carried out into the incidence of psychosis and opi-
ate dependency in Oslo.
16.4 Examples of best practice and recommendations for future policy
Persons with dual diagnosis often have negative experiences of treatment. Establishing good rela-
tions with helpers in the social and health services takes a long time in itself.  Many in the target
group have good relations with street-level facilities and low-threshold institutions that see it as their
duty to cover their most basic needs, such as accommodation, food and keeping warm.
It may be necessary to link these services to specialist services in order to create the required
alliances. 
New organisation of services
The examples in chapter16.3 provide experience of the effect of different programmes or individual
interventions. Since the Norwegian policy aims to prevent persons with co-morbidity from being
excluded from the general services, we will include an example where a local community has organ-
ised its services in such a way that user influence and an integrated approach are central elements.
The example is from a small municipality in Northern Norway. 
“The Øksnes project”
Øksnes municipality set up a Council for local psychiatry with users in the majority in 1997. The
Council evaluates existing services and proposes measures relating to the services provided in the
fields of alcohol and drug care and mental healthcare.  
A survey showed that 16 persons with compound psychiatric and alcohol/drug problems fell outside
the services offered. They were constantly passed between the municipal help services, the psychi-
atric hospital, the clinic for drug and alcohol problems and other mental healthcare services. The
doctors in the municipality had a heavy workload relating to the fact that drug use in this group was
out of control.  Contact with the patients was characterised by acute emergency solutions involving
short compulsory admissions to institutions requiring transport by plane or taxi/ambulance. The con-
sultant for drug and alcohol problems, the psychiatric health worker, doctor and milieu therapist in
the users’ arena have been formed into a professional team, without barriers and appointments,
with responsibility for social work and health measures. The team is physically accessible between
8:00 and 22:00, and by phone at night and at weekends. 
The premises used by the professional team, the “Meeting place”, is rented by the users. Up to 30
users come here daily. Various self-help groups have been set up and they help each other with prac-
tical tasks. For many of them this “haven” is a first step out of an isolated existence. It will be devel-
oped in cooperation with users, and with genuine user participation. The users will be able to influ-
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ence what happens to both individuals and the group, but families and other involved persons will
also be taken into consideration. 
Through cooperation with the local press, among others, a lot of effort was put into changing atti-
tudes in the community, and the media monitored how user participation was put into practice.
There was some resistance among staff to introducing a more accessible and flexible system in
which those providing the services had to work more irregular hours than before. 
Today, the team also includes a representative of local labour market enterprises. Staff in non-munic-
ipal positions (the Team for adult psychiatry and the Team for child and youth psychiatry) now have
regular working hours in the municipality. Integrated into the municipal services, they are thus part
of preventive efforts instead of being brought in on an emergency basis as they were previously.
Municipal employees receive continuous guidance and updating. The evaluation of the users is done
while they are in their home environment. 
The “Meeting place” triggered a need for help, day and night.  During the Meeting place’s first year
the project staff were very much in demand, but this fell off as time passed. The users stated that
housing was problem number one. Good housing solutions have been the key to reaching this user
group with other forms of help. Efforts have also been put into adapting workplaces, in coopera-
tion with a local labour market enterprise among others. 
This is an important part of the project that provides relief for the specialists and that can be used
“constructively” instead of just meeting a need for acute treatment.  The number of acute and com-
pulsory psychiatric admissions has fallen sharply. Control of the use of medication has improved for
the group with compound problems. The evaluation of the project showed that the target group’s
situation had improved and that the public sector has “saved” the cost of hospital admissions, social
security and welfare benefits (Foss 2000).
Case management
There is a need in Norway to coordinate services provided under different Acts and to adapt differ-
ent local services and treatment measures. Various case-management models are being developed
in work with psychiatric patients, including “Coordination of Psychosocial Work” (CPS) for the fol-
low-up of patients with persistent and serious mental illnesses. The method consists of drawing up
and implementing an action plan in cooperation with the user, which the coordinator uses to fol-
low him/her up over time. Providing guidance for all those involved and ensuring organisational
support in the existing services are central elements. CPS is not intended to replace traditional treat-
ment. However, coordination often uncovers unrecognised treatment needs that are unknown to
the specialist services.
CPS will alternate between user-oriented rehabilitation and care work and work on adapting the
network of interventions. A few of the users in the trial project had dual diagnoses. The CPS model
works on the assumption that users will manage to attend appointments. This was a limitation in
work with this group. The group that developed the CPS model in Norway has drawn attention to
some experiences (Evjen 2003) involving users with particularly compound problems, as is often the
case with dual diagnoses: 
• The personal coordinator must take an outreach approach and be accessible to a high degree.
Systems should be developed whereby it is possible to alternate between counselling, treatment,
care and rehabilitation according to the user’s needs. Treatment – with cure as its goal – should
only be included as one of several strategic options, that can be used for limited periods if expe-
dient.  
• Emphasis on building good alliances. One should, for instance, drop the demand for urine sample
controls if this creates mistrust and prevents the development of good relations. 
• Needs-based, not crisis-based follow-up. 
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• Individual adaptation, matching different treatment methods to the user’s different needs. 
• Broaden the understanding of what constitutes the goal of the work – be it improvement of symp-
toms, reducing the experience of stress or easing the situation for the user’s family. 
• Register the benefits of one’s efforts. Increase understanding for “measuring” the results of inter-
ventions. 
• Pay great attention to the risk of a relapse of symptoms – which for this target group will often
have major consequences. 
• Work systematically on preventing crises in individual users, be alert with respect to a deteriora-
tion of symptoms and initiate solution-oriented discussions. “What have I done previously in cor-
responding situations?”
• Planned interventions must appeal to the user’s real needs. When “getting high” is an important
part of the user’s life, interventions cannot be based on full freedom from intoxicants.
The possibilities of evaluating interventions aimed at the co-morbidity group are limited. In order to
measure the effect of interventions, it is necessary to carry out initial evaluations or diagnoses of per-
sons who are the subject of interventions and then repeat them after the intervention. Only after
stabilisation has taken place will it be possible to tell whether the person has an enduring mental
health problem or whether it is drug-triggered, i.e. is a consequence of the abuse. One major chal-
lenge is to base the intervention firmly on the user’s needs and not on the existing services that
established facilities can offer. Changes must also be made at the societal and system level where
attitudes, theories and methods need to be changed so that the services do not exclude “difficult”
groups of this type and so that they feel that they have sufficient “dual competence” or “cross com-
petence”. 
Treatment adapted to different patient groups
A study has been carried out summarising the treatment of clients with both alcohol/drug abuse
problems and psychopathology based on the findings from six different Norwegian treatment stud-
ies carried out during the period 1967-1990 that showed a high incidence of mental illnesses, most-
ly personality disorders, anxiety and depression among patients (Vaglum 1996). One conclusion of
this treatment study was that aggressive, impulsive behaviour was best treated by confrontational,
structured group therapy combined with family therapy. Patients who were depressed or anxious
benefited more from individual psychotherapy and supportive group therapy. 
Early intervention
The project, Early Intervention in Psychotic Disorders in Rogaland aims to reach young people from
as early as the age of 15, in order to start the treatment of psychotic conditions early on, based on
recognition of the fact that the longer the psychosis remains untreated, the easier it will manifest
itself. One method is the establishment of a discovery team. The team will provide follow-up lasting
at least five years. The project started in 1997 and has had 600 patients. Thirty per cent of those
reached by the project, abuse alcohol/drugs as well having psychosis problems. The proportion with
dual diagnosis is greater than in previous Norwegian surveys. One reason may be that the  project
searches so thoroughly for patients and registers both symptoms in detail. 
The project’s experience is that many of the alcohol/drug abusers show significant improvement
when they receive treatment for their psychoses. It appears that the need to “get high” thereby
decreases. So far, too little is known to be able to decide whether psychosis or near psychosis in this
group is triggered by substance abuse or whether these conditions could have been prevented if the
patient had not used drugs. 
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Recommendations for future policy for the area23
• Integrated rather than isolated help. The treatment must be directed simultaneously at the alco-
hol/drug abuse and the mental illness.
• The capacity to intervene early should be increased.
• The therapeutic teams should develop special treatment methods designed for dual diagnosis
patients.
• The therapists must reach out to the clients, understand them on their own terms and find an
approach that suits the patient. 
• Concrete help must be available in the client’s local community. A secure framework must be cre-
ated so that the client can be helped to achieve better control of his/her alcohol/drug use and psy-
chiatric symptoms. 
• The services must comprise comprehensive rehabilitation that includes the establishment of a
secure housing situation, stabilisation of the client’s finances, family support, vocational training,
crisis measures and stress management.
• The possibilities for admission to a psychiatric in-patient department must be improved.
• Medical treatment must be part of the programme.
• Follow-up responsibility must be expected to last for several years.
• The treatment programmes/therapists must build good alliances with the clients and focus on the
successful formation of attachments to private and pubic networks.  
In light of the Norwegian Board of Health’s studies of the need for specialised treatment facilities for
those alcohol/drug abusers with the most serious mental illnesses, the Ministry of Health (the
Ministry of Health and Social Affairs 2001) recommends the establishment of an ambulant team that
can reach out to and follow up patients at home as required, and “psychiatric youth teams” that
work externally and on an outreach basis.  It is possible to find, both in the trial projects with ambu-
lant teams and in the alcohol/drugs sector, good Norwegian examples that give grounds for believ-
ing that therapists who are able to spend enough time on cases often case succeed with treatment
on a voluntary basis. 
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